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Background: Malnutrition is highly prevalent in hospital settings, with adverse effects on 
patient outcomes. Up until recently, there have been no universally accepted diagnostic 
criteria for malnutrition to aid clinical practice. In response to the needs of the clinical 
nutrition and medical communities, the Global Leadership Initiative on Malnutrition (GLIM) 
has proposed a set of core diagnostic criteria for diagnosing adult malnutrition across different 
healthcare settings. These criteria are consensus based and need validation.  
 
Aims and objectives: This study aimed to investigate the criterion validity of the GLIM 
criteria for the malnutrition diagnosis using ICD-10 diagnostic codes E.44.0 and E.43 as 
reference, and to investigate the prevalence of malnutrition and nutritional risk as identified 
by NRS-2002 among hospitalized patients at Haukeland University Hospital.   
 
Methods: This study is a cross-sectional analysis of anthropometrical and nutritional 
indicators from inpatients at six departments at Haukeland University Hospital, collected as 
part of the MALNUTRA-study. Nutritional risk status was determined based on NRS-2002 
scores collected from previous study personnel. Based on the available data, patients were 
assessed retrospectively using the ICD-10 diagnostic codes E.44.0 and E.43, and by applying 
six combinations of GLIM’s phenotypic and etiologic criteria: A) Weight loss and reduced 
food intake B) Weight loss and inflammation C) Low BMI and reduced food intake D) Low 
BMI and inflammation E) Reduced muscle mass and reduced food intake F) Reduced muscle 
mass and inflammation. Reduced muscle mass was assessed by mid arm muscle 
circumference, and CRP ≥ 5 mg/dl was used as an indicator of inflammation. Agreement 
(Cohen’s Kappa, percent agreement) and validity (sensitivity, specificity, positive predictive 
value and negative predictive value) statistics were performed to assess criterion validity. 
 
Results: 326 patients (71 years (IQR 18), 53% men) were assessed. NRS-2002 identified 44% 
as in nutritional risk. ICD-10 identified 37% as malnourished, of which 28% were moderately 
malnourished (E.44.0) and 9.5% were severely malnourished (E.43). GLIM identified 35% as 
malnourished, of which 13% were moderately malnourished and 22% were severely 
malnourished. The GLIM criteria displayed fair criterion validity (sensitivity 59.0%, 
specificity 79.4%) and agreement (k=0.389, agreement 72%) when compared to the ICD-10 
diagnostic codes E.44.0 and E.43. When compared based on moderate malnutrition status, 
 v 
GLIM’s criterion validity was rated as poor (sensitivity 18.7%, specificity 89.8%) and 
agreement was poor (k=0.102, agreement 70%) when compared to ICD-10 E.44.0. However, 
when compared based on severe malnutrition status the GLIM criteria displayed good 
criterion validity (sensitivity 87.1%, specificity 84.4%) and moderate agreement (k=0.445, 
agreement 85%) when compared to ICD-10 E.43.  
 
Conclusion:  
The newly proposed GLIM criteria displayed fair criterion validity and agreement for the 
diagnosis of malnutrition, using ICD-10 as reference. However, this was not consistent across 
severity grades.  
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Malnutrition in hospitalized patients predisposes to disease, impairs recovery from disease, 
and adversely affects both body and mental function, as well as clinical outcome (1). Still, 
malnutrition is a highly prevalent condition in hospitals (2), often left unrecognized and 
untreated (3). Up until recently, there have been no universally accepted diagnostic criteria for 
malnutrition to aid clinical practice. In response to the needs of the clinical nutrition and 
medical communities, the Global Leadership Initiative on Malnutrition (GLIM) (4) has 
proposed a consensus-based set of core diagnostic criteria for diagnosing adult malnutrition 
across different healthcare settings.  
 
1.1. Definition  
There is a variety of proposed definitions and diagnostic criteria for malnutrition in the 
literature (4-12). A universally accepted definition that adequately reflects the 
pathophysiology and clinical outcome of malnutrition is still wanted by global nutrition and 
medical societies (13, 14). Simply put, malnutrition translates to “bad nutrition” (1). By this 
definition, malnutrition is an umbrella term that includes a wide range of nutritional disorders. 
One common approach is to distinguish between over-or undernutrition, i.e. excess or lack of 
dietary protein or energy, also referred to as protein-energy malnutrition. Malnutrition can 
also refer a lack of specific vitamins and minerals, therefore including micronutrient 
deficiencies. For the current thesis, the following definition of malnutrition will be used:   
 
“Malnutrition is a state resulting from lack of intake or uptake of nutrition that leads 
to altered body composition (decreased fat free mass) and body cell mass leading to 
diminished physical and mental function and impaired clinical outcome from disease” 
 
By this definition, malnutrition will be interpreted in the “undernourished” as a result of “a 
lack of protein or energy” sense of the term. Furthermore, it will be used synonymously with 
disease-related malnutrition (DRM), which is the sub-classification of malnutrition primarily 
encountered among adult and elderly in a hospital setting (15).  
 
1.1.1. Sub-classifications of malnutrition 
Following the general definition, malnutrition in a clinical setting can be further classified 
based on etiology (6), as, illustrated in Figure 1.  
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Figure 1. The diagnosis tree of malnutrition. From (10).   
 
In a clinical setting malnutrition mainly arises as a consequence of disease (5, 15),  therefore 
termed disease-related malnutrition (DRM). DRM can develop as a result of 1) Pure 
starvation without inflammation, typically seen in conditions such as dysphagia, dementia or 
anorexia nervosa 2) Chronic disease with prolonged inflammation of a mild or moderate 
degree e.g. in cancer or chronic lung disease 3) Acute disease or injury with severe 
inflammation such as in patients undergoing extensive surgery or treatment for extensive 
burns. There is also malnutrition without disease, which is seen more frequently in developing 
countries and will not be discussed further in this thesis. It is important to correctly identify 
the different sub-classifications of malnutrition, as it has consequences for planning of 
treatment and patient prognosis (8).  
 
1.2. Prevalence 
Malnutrition is common in hospitalized patients. Prevalence rates vary depending on which 
nutritional screening or assessment tools are used to define it, and which population is being 
investigated. Particularly the lack of a universal definition of malnutrition has been pointed to 
as part of the issue, as different criteria and cut-off values make comparisons difficult (7, 16). 
Therefore, the actual prevalence of malnutrition in hospitals is unknown. Global estimates 
range between 10- 70% (5, 15, 17-19). As for Norway, it has been reported that 29-60% of 
hospitalized patients are at risk of malnutrition (20-22) and 39-65% are malnourished (23, 
24). Although malnutrition can occur at any age or condition, malnutrition is more frequent in 
the elderly, patients with multiple comorbidities, critically ill, and in specific diseases or 
conditions such as dementia, malignant-, GI-, renal -, respiratory and heart disease (10, 25). 
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1.3. Consequences of malnutrition  
It is well established that malnutrition has negative implications for hospitalized patients’ 
clinical outcomes. Malnutrition is associated with increased morbidity, risk of complications 
(26) and infections (27), increased mortality (28), longer length of stay (LOS) at the hospital, 
and more hospital readmissions (7, 17). It is of important note, that this also applies to patients 
at risk of developing malnutrition. Tangvik et. al. (29) found that patients answering 
positively on the initial screening of NRS-2002 had significantly longer LOS, increased 
mortality and morbidity, and were more likely to be readmitted compared to patients not at 
risk. As a result, malnutrition has a significant economic impact on health care services (17, 
30). In a Dutch study (31) it was estimated that the total additional cost of treating adult DRM 
was €1.9 billion per year or 2.1% of the total national health expenditure (2011 figures). 
Furthermore it has been estimated Norwegian Specialiced Health Services can save 800 
million NOK, or approximately 1% of its total expenditures, by preventing and treating 
malnutrition through individualized nutrition care (2010 figures) (32).  
 
1.4. Etiology  
The underlying reasons for the development and exacerbation of DRM are many and not fully 
understood. Central factors include inadequate dietary intake, together with increased 
nutritional requirements or an impaired absorption/assimilation of nutrients (33). The 
underlying mechanisms differ based on the presence or absence of inflammation.  
 
1.4.1. DRM with inflammation  
DRM with inflammation is described as a catabolic condition characterized by an 
inflammatory response due to an underlying disease (10). The inflammatory state has several 
negative implications. Inflammation influences metabolism, shifting it towards a catabolic 
state of increased breakdown of body fat and muscle (34). Breakdown of muscle mass is more 
rapid in acute disease and injury but will also occur in chronic disease at a slower rate over a 
longer period (35). Inflammation also increases energy and protein requirements, by elevating 
resting energy expenditure and nitrogen excretion. Furthermore, inflammation associated loss 
of appetite (anorexia) can limit dietary intake so that nutritional requirements are not met. 
This contributes to worsening losses of total body weight and muscle mass, thus making 
malnutrition associated with impaired functional status and worsened clinical outcome (15). 
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1.4.2. DRM without inflammation  
DRM without inflammation is caused by etiologic mechanisms not driven by inflammation 
(10). Common examples include conditions that obstruct food intake such as dysphagia or 
neurologic disorders such as stroke or dementia. Conditions like anorexia nervosa or 
depression can negatively impact appetite, and malabsorptive conditions like IBD or Crohn’s 
disease can limit nutrient uptake from the GI-tract. DRM without inflammation differs from 
its inflammatory counterpart in that metabolism decreases in response to inadequate 
nutritional intake (35). Therefore, loss of body weight is slower than in inflammatory-driven 
DRM.  
 
1.4.3. Other etiologic factors 
Several factors contribute to the development of DRM, irrespective of the presence or absence 
of inflammation. Age-related decrease in appetite and/or dietary intake, coined “anorexia of 
ageing”, is frequently seen in the elderly (36). Common symptoms related to disease or 
medical treatment, such as nausea, sore mouth, diarrhea or constipation, will also contribute to 
loss of appetite and impaired nutrient absorption (4). Nutritional status has also been shown to 
deteriorate during the hospital stay (25). Lack of knowledge and interest among health 
personnel regarding the patients nutritional status and requirements has been described as 
contributing factors (37). In a 2006 study (38) regarding the quality of health care provided to 
hospitalized or institutionalized elderly in Norway, doctors and nurses reported that they 
thought patients nutritional requirements were inadequately looked after. The main reason 
provided was a lack of resources and access to qualified health personnel, dietitians.   
 
1.5. Nutritional screening and nutritional assessment  
The first step of a systematic nutrition care process is screening for nutritional risk. Risk 
screening can be defined as “a rapid process performed to identify subjects at nutritional risk” 
(10). Patients’ nutritional status will often deteriorate due to unrecognized nutritional risk 
(37). Therefore, risk screening should be carried out at first contact, or within the first 24-48 
hours after hospital admission (10). Thereafter, patients should be reassessed weekly. Thus, 
risk screening helps to rapidly determine if further action is needed in order to prevent 
deterioration of a patient’s nutritional status. Patients identified as being at nutritional risk 
should always proceed to a full nutritional assessment. A nutritional assessment can be 
defined as “a more detailed, more specific, and in-depth evaluation of a patient’s nutritional 
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state” (39). A nutritional assessment should be carried out by health personnel with nutritional 
competence, such as dietitians. The assessment forms the basis for a malnutrition diagnosis, 
and for specific nutritional care plans adapted to the individual patient (10). Obtaining an 
accurate assessment of nutritional status is complicated by the lack of universally accepted 
diagnostic criteria with clearly defined cut-off values (14). In other words, there is no “gold 
standard” available to diagnose malnutrition (40). As a result there is published more than 50 
tools for risk screening and nutritional assessment (39). Which diagnostic criteria are used, 
how the selection criteria are weighed, how much time is needed to perform the screening or 
assessment, or whether the tool is validated in the population under question, are some of the 
factors that a clinician should consider when choosing a tool. A selection of widely accepted 
screening and assessment tools, along with some of the most common indicators used to 
assess nutritional status, is presented in Table 1.  
 
Table 1. Indicators used in selected tools for risk screening and nutritional assessment. 
Adapted from (4).  
 






ESPEN 2015 b 
(8) 




Etiologic       
Reduced food intake X X X X X X 
Disease burden/ 
inflammation 
X X X X X X 
Symptom       
Anorexia  X    X 
Weakness  X    X 
Phenotypic       
Weight loss X X X X X X 
BMI X X X X   
Fat free mass  X  X X X 
Fat mass     X X 
Fluid retention/ ascites      X X 
Muscle function     X X 
“X” marks the use of an indicator by a tool.  
a Tool used for screening 
b Tool used for assessment 
Abbreviations: NRS-2002, Nutritional Risk Screening 2002; MNA-SF, Mini Nutritional Assessment- Short Form; MUST, 
Malnutrition Universal Screening Tool; ESPEN, European Society for Clinical Nutrition and Metabolism; ASPEN, American 






1.6. Diagnostic criteria 
1.6.1. Reduced food intake 
The role of reduced food intake in the development of malnutrition is well established. It can 
have multiple causes, which are further elaborated in Section 1.4. In a hospital setting, 
questions regarding food intake before admission can provide useful information. Bedside 
food records that are filled out by health personnel or the patients themselves, preferably for 
more than two days, can also be used for quantifying food intake (10). Other methods include 
24-hour recalls and food frequency questionnaires (FFQs) (45).  
 
1.6.2. Involuntary weight loss 
Measurement of body weight is part of routine clinical practice when assessing nutritional 
status (46). Body weight equals the sum of both fat-free mass and fat mass, therefore changes 
in body weight can represent changes in muscle and fat, as well as changes in fluid balance. 
Depending on the situation, this should be considered when assessing the clinical impact of 
changes in weight. For example, day to day physical fluctuations in fluid balance in healthy 
individuals are not likely to significantly impact measurements, but excess fluid (ascites or 
oedema) related to liver- or kidney disease has the potential for obscuring changes in muscle 
or fat mass (46) Which cut-offs used for percentage weight loss over a given time period, will 
vary between screening or assessment tools. Unintentional weight loss > 10% over 3-6 
months is generally considered as clinically significant as it implies underlying disease and 
loss of functional status (39). For inpatients, weight should be measured at least once a week, 
and repeatedly over time in order to follow development (10).  
 
1.6.3. BMI 
Body mass index (BMI) is widely used in clinical practice as a quick and relatively easy to 
use indicator of nutritional status (39). BMI has well established validity, and low BMI is 
associated with increased mortality, complications after surgery, risk of infection and LOS 
(46). While there are regional differences, WHO provide generally accepted cut-off values 
(47) where underweight is defined as BMI under 18.5 kg/m2. Due to the increasing prevalence 
of overweight and obesity in large parts of western populations, it has been noted that the use 
of BMI in nutritional assessment can be limited (4). In some cases, a substantial weight loss 
would be required before being identified as malnourished based on solely BMI as an 
indicator.   
 7 
 
1.6.4. Disease burden/inflammation  
Malnutrition is associated with metabolic changes caused by an inflammatory response 
triggered by disease or injury (48). This has been described in more detail in Section 1.4.1. 
Thus, inflammation, often used interchangeably with disease burden, has become a widely 
accepted component of nutritional assessment (4). How to best measure inflammation in 
clinical settings is not agreed upon. A subjective approach would be to assess the clinical 
diagnosis and use clinical judgement to consider the degree of associated inflammatory 
response. For example, diseases such as cancer, chronic obstructive pulmonary disease 
(COPD), inflammatory bowel diseases, congestive heart failure, or chronic kidney disease are 
usually associated with systemic inflammation of a mild- to moderate degree (10). Patients 
suffering from acute disease, injury or trauma, such as major burns or infections, are in a 
highly catabolic state with high levels of inflammation (49). The degree of inflammation can 
also be assessed using objective biochemical markers as supportive measures. ESPEN 
guidelines suggest elevated serum C-reactive protein (CRP) and reduced serum 
concentrations of albumin or pre-albumin (10). Although these biochemical markers have 
been shown to predict adverse health outcomes, they are primarily markers of inflammation, 
and not nutritional status (50). Therefore, they should not be used in isolation when assessing 
nutritional status.  
 
1.6.5. Reduced muscle mass 
An accurate and valid assessment of body composition is considered essential when assessing 
nutritional status (46). Loss of muscle mass, or fat free mass, is considered a reliable indicator 
for assessing the severity of malnutrition, and for predicting adverse health outcomes (51). 
Furthermore, loss of muscle mass is generally accompanied by a loss of muscle function. 
Studies show that reduced muscle function, measured by grip strength, is associated with a 
loss of functional status in hospitalized patients (52). There is currently no agreement on 
which method best measures the loss of muscle mass, or which cut-off values to apply (4). 
Some methods include imaging techniques such as Dual-energy absorptiometry (DXA), 
ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI). Bioelectrical 
impedance (BIA) is considered a less invasive, less expensive and more available bedside 
assessment method (53). Anthropometric measurements such as calf or arm muscle 
circumference can also be used to assess nutritional status, as muscle size reflects protein 
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reserves (54). Choice of methods may vary according to available resources and time. It has 
been shown that different ways to measure muscle mass may provide different results (55).  
 
1.7. Tools used to identify nutritional risk and malnutrition  
1.7.1. NRS-2002 
Nutritional risk screening (NRS) 2002 is a tool developed for nutritional risk screening in 
adult hospitalized patients, and recommended by ESPEN (41). The screening tool is two-part, 
with a quick to use initial screening consisting of only four questions for easier identification 
of patients that could be at nutritional risk. These questions are simple (yes or no) and assess 
the patients BMI, involuntary weight loss during the last 3 months, reduced food intake 
during the last week, and disease severity. If the answer is “yes” to any of the initial 
questions, a more comprehensive evaluation follows where the patient is scored based on the 
degree of nutritional impairment, disease severity and age (over or under 70 years old). A 
patient is classified as being at nutritional risk if the total score is over or equal to 3. The full 
NRS-2002 questionnaire is presented in Table 2. At Haukeland University Hospital (HUH), 
risk screening using NRS-2002 is incorporated into a larger risk assessment tool called 
“Trygg pleie”. “Trygg pleie” was implemented by the Norwegian Patients Safety Programme 
“In Safe Hands 24-7” (56) as one of the nutrition strategies described in the National 




Table 2. Identification of nutritional risk using Nutritional Risk Screening 2002 (NRS-2002) 
 
Score Nutritional status 
( » degree of impairment) 
Disease severity  
(» stress metabolism) 
 0 – Absent Normal nutritional status Normal nutritional requirements 
 1 – Mild Weight loss > 5% last 3 months, or food intake 50-75% of 
normal requirements the last week.  
Hip fracture*, patients with chronic diseases/conditions*, in 
particular those with acute complications: liver cirrhosis, COPD*. 
Chronic hemodialysis, diabetes, cancers.  
 2 – Moderate Weight loss > 5% last 2 months, or BMI 18.5-20.5 + 
impaired general condition, or food intake 25-50% of normal 
requirements the last week. 
Major abdominal surgery*, stroke*.  
Severe pneumonia, hematologic malignancies  
 3 – Severe Weight loss > 5% last 1 month (> 15% last 3 months), or 
BMI < 18.5 + impaired general condition, or food intake 0-
25% of normal requirements the last week. 
Head trauma*, bone marrow transplantations* 
Intensive care patients (APACHE score > 10) 
Total score Calculation procedure: 
1) Score 0-3 based on nutritional status + score 0-3 based on disease severity (Only one score from each component, the most 
severe score should be selected).  
2) If age ≥ 70 years, add 1 to the total score.  
3) If age corrected total score ≥ 3, patient is at nutritional risk and nutritional support must be implemented.  
 
* Indicates that a study directly supports the categorization of patients based on the specific disease. Diagnoses in italics are based on the prototypes described below: 
Score 1: A patient with chronic disease hospitalized due to complications associated with a chronic disease. The patient is weak, but not bedridden. Protein requirements are 
increased but can be covered by food intake per os and/or oral nutrition support in most cases.  
Score 2: A patient bedridden due to disease e.g. after major abdominal surgery. Protein requirements are substantially increased, but can be covered, even if artificial nutrition 
support is required in many cases.  
Score 3: An intensive care patient requiring e.g. assisted ventilation. Protein requirements are increased and cannot be covered by artificial nutrition support. Catabolism of 
body protein and associated nitrogen losses can be significantly reduced by nutrition support.  
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; APACHE, acute physiology and chronic health evaluation. 
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1.8. Subjective global assessment 
Subjective global assessment (SGA) is a comprehensive tool considered by some as a semi-
gold standard in nutritional assessment of hospitalized patients (57). SGA was originally 
developed in an adult surgical population (44) but has been widely used in hospital nutritional 
assessment since. It has been validated and is predictive of health outcomes associated with 
impaired nutritional status in hospitalized patients (58). SGA is also two-part, assessing 
nutritional status based on 1) clinical history and 2) physical examination. When assessing the 
clinical history, information is collected weight loss, food intake, GI-symptoms, functional 
status and metabolic demand related to the disease/condition. During the physical exam, loss 
of muscle mass, subcutaneous fat and presence of oedema is evaluated. This information 
forms the basis from which the health personnel subjectively categorize patients as well 
nourished (SGA A), moderately or suspected of being malnourished (SGA B) or severely 
malnourished (SGA C). 
 
1.9. ICD-10 
The International Statistical Classification of Diseases and Related Health Problems (ICD) is 
a classification- and diagnostic system owned and published by the World Health 
Organization (WHO) (59). Available to all member countries, the ICD provide diagnostic 
codes for easy comparison of health-related data between countries. The ICD system is 
periodically updated and is currently on the 10th edition (ICD-10). ICD-10 is currently being 
used by the Norwegian Specialist Health Service and include three codes for malnutrition: 
E.46 Unspecified protein-/energy malnutrition, E.44.0 Moderate protein-/energy malnutrition 
and E43 Severe protein-/energy malnutrition. The diagnostic code E.46 is used 
interchangeably with nutritional risk, is based upon scores from select nutritional screening or 
assessment tools, for example, a total NRS-2002 score ≥ 3. The diagnoses of E.44.0 and E.43 
are based on an assessment of involuntary weight loss and BMI, either separately or in 
combination. For E.44.0 food intake with concurrent inflammation is also considered. The 
diagnostic criteria for E.46, E.44.0 and E.43 are presented in full in Table 3. 
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Table 3. Criteria for ICD-10 malnutrition diagnoses E.46, E.44.0 and E.43.  
 
Code Term Criteria a 
  Weight loss (%) Low body mass 
index (kg/m2) 
Low body mass index and 
weight loss 
Reduced food intake and 
inflammation 
Nutritional screening-or 
assessment tool scores 
E.46 Unspecified protein-
/energy malnutrition   
N/A N/A N/A N/A NRS-2002: ≥ 3  
MUST: ≥ 2 
MNA Part 1: ≤ 11 
PG-SGA SF: ≥ 2  
E.44.0 Moderate protein-
/energy malnutrition  
> 10% last 3-6 
months, or > 5% 
last 2 months 
< 18.5 if < 70 
years or < 20 if 
>70 years 
< 20.5 (< 22 if > 70 years) 
and concurrent weight 
loss > 5% last 6 months 




PG-SGA grade B 
E.43 Severe protein-
/energy malnutrition  
> 15% last 3-6 
months, or > 5% 
last 1 month 
< 16 if < 70 
years or < 18.5 
if >70 years 
< 18.5 (< 20 if > 70 years) 
and concurrent weight 
loss > 5% last 3 months 
N/A PG-SGA grade C 
 
a Requires at least 1 criterion for diagnosis.  
Abbreviations: N/A, not available; NRS2002, Nutritional Risk Screening 2002; MUST, Malnutrition Universal Screening Tool; MNA, Mini Nutritional Assessment; PG-SGA 
(SF), Patient Generated Subjective Global Assessment (Short Form); ER, estimated requirements. 
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1.10. The Global Leadership Initiative on Malnutrition  
1.10.1. Background 
It is evident that there is a lack of consensus on a definition of malnutrition, and subsequently 
diagnostic criteria for use in both clinical settings and in nutrition research (4, 10, 14). 
Although most approaches to define malnutrition are similar and largely use the same 
diagnostic criteria (13), one universally accepted approach to define malnutrition is needed in 
order to standardize clinical practice. In response to the needs of the clinical nutrition and 
medical communities, the Global Leadership Initiative on Malnutrition (GLIM) (4) recently 
proposed a consensus- based approach, describing core diagnostic criteria for diagnosing 
adult protein-energy malnutrition across different healthcare settings worldwide.  
 
1.10.2. Development 
The GLIM criteria were developed over a 3-year period between 2016 and 2018, as a 
collaborative initiative between four of the major global clinical nutrition societies: American 
Society for Parenteral and Enteral Nutrition (ASPEN), European Society for Clinical 
Nutrition and Metabolism (ESPEN), Federación Latinoamericana de Terapia Nutricional, 
Nutrición Clínica y Metabolismo (FELANPE), Parenteral and Enteral Nutrition Society of 
Asia (PENSA). GLIM consisted of a core leadership committee and a supporting working 
group of representatives from diverse disciplines. The consensus procedure consisted of a 
series of face-to-face meetings, telephone conferences and e-mail communications. In 2019 
the results were published in a statement paper (4), presenting a three-step approach for 
detecting and diagnosing malnutrition. 
 
1.10.3. A three-step approach 
Originally presented as a two-step approach, GLIM is in practice more of a three-step 
approach. Starting with screening for nutritional risk, followed by diagnostic assessment and 











Figure 2. The GLIM-approach for the diagnostic assessment of malnutrition. Modified from 
(4).   
 
Similar to previously described approaches, GLIM also recommends that the first step of the 
process should always be to identify patients at nutritional risk using any validated screening 
tool. Patients at risk of developing malnutrition should then continue to the second step of a 
more in-depth diagnostic assessment based on the consensus based diagnostic criteria, 
referred to as the GLIM criteria. For the diagnosis of GLIM defined malnutrition a minimum 
of one phenotypic and one etiologic criterion must be present. The phenotypic criteria are 
clinical features that reflect the severity of malnutrition and include involuntary weight loss, 
low BMI and reduced muscle mass. The etiologic criteria include reduced food intake or 
assimilation of nutrients, and the presence of inflammation due to disease. Lastly, GLIM 
recommends grading the severity of malnutrition based upon the relevant phenotypic criteria 
from the previous step. See Table 4 for more detail on the GLIM criteria, including suggested 




Table 4. Phenotypic and etiologic criteria for the GLIM diagnosis of malnutrition. With thresholds for severity grading into Stage 1. Moderate 
and Stage 2. Severe Malnutrition. From (4).  
 
 Phenotypic Criteria Etiologic Criteria 
 Weight loss (%) Low body mass 
index (kg/m2) 
Reduced muscle mass a Reduced food intake or assimilation b-c Inflammation d-f 
Malnutrition g >5% within past 
6 months, or 
>10% beyond 6 
months 
<20 if <70 years 
or < 22 if > 70 
years 
Reduced by validated body 
composition measuring 
techniques a 
<50% of ER > 1 week, or any reduction 
for >2 weeks, or any chronic GI 
condition that adversely impacts food 
assimilation/absorption b-c 
Acute disease/ 
injury d-f, or 
chronic disease-
related e-f 
Stage 1. Moderate 
Malnutrition h  
5-10% within 




<20 if <70 years 
or < 22 if > 70 
years 
Mild-to-moderate deficit (per 




Stage 2. Severe 
Malnutrition h  
>10% within 
past 6 months 
or >20% beyond 
6 months 
<18,5 if <70 
years or < 20 if 
> 70 years 
Severe deficit (per validated 




a E.g., Fat free mass index (FFMI, kg/m2) by dual-energy absorptiometry (DXA), or other corresponding body composition methods such as bioelectrical impedance analysis 
(BIA), CT or MRI. When not available or by regional preference, physical examination or standard anthropometric measures like mid-arm muscle or calf circumferences may 
be used. Functional assessments like hand-grip strength may be considered as a supportive measure.  
b Consider gastrointestinal symptoms as supportive indicators that can impair food intake or absorption e.g., dysphagia, nausea, vomiting, diarrhea, constipation or abdominal 
pain. Use clinical judgment to discern severity based upon the degree to which intake or absorption are impaired. Symptom intensity, frequency, and duration should be noted. 
c Reduced assimilation of food/nutrients is associated with malabsorptive disorders like short bowel syndrome, pancreatic insufficiency and after bariatric surgery. It is also 
associated with disorders like esophageal strictures, gastroparesis, and intestinal pseudo-obstruction. Malabsorption is a clinical diagnosis manifest as chronic diarrhea or 
steatorrhea. Malabsorption in those with ostomies is evidenced by elevated volumes of output. Use clinical judgment or additional evaluation to discern severity based upon 
frequency, duration, and quantitation of fecal fat and/or volume of losses. 
d Acute disease/injury related. Severe inflammation is likely to be associated with major infection, burns, trauma or closed head injury. Other acute disease/injury-related 
conditions are likely to be associated with mild to moderate inflammation. 
e Chronic disease related. Chronic or recurrent mild to moderate inflammation is likely to be associated with malignant disease, chronic obstructive pulmonary disease, 
congestive heart failure, chronic renal disease or any disease with chronic or recurrent inflammation. Transient inflammation of a mild degree does not meet the threshold for 
this etiologic criterion. 
f C-reactive protein may be used as a supportive laboratory measure. 
g Requires at least 1 phenotypic criterion and 1 etiologic criterion for diagnosis of malnutrition. 
h Severity grading is based upon the noted phenotypic criteria while the etiologic criteria are used to provide the context to guide intervention and anticipated outcomes. 
Abbreviations: GI, gastro-intestinal; ER, energy requirements. 
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1.10.4. Assessing the validity of GLIM 
Assessing validity of a tool refers to testing if the tool detects what the tool is indented to 
detect (60), which in the case of GLIM is protein-energy malnutrition (4). Valid tools are 
important as they provide accurate identification of patients at nutritional risk or malnourished 
or nutritional risk or that are malnourished, which in turn promotes referral to a dietitian (61). 
There are different types of validity, which are defined in Table 5. Criterion validity is 
considered the superior type of validity (60).  
 
Table 5. Definitions of types of validation. From (40, 62).  
 Definition  Description  
Content validity  Assesses the relevance and 
completeness of a tool's 
content.  
E.g. If the selected GLIM 
criteria are relevant for 
assessing malnutrition.  
Construct validity  Assesses the extent to which a 
tool performs in accordance 
with theoretical expectations. 
E.g. If prevalence of GLIM 
defined malnutrition differs 
among groups in which 
prevalence is expected to vary, 
such as between hospital and 
community.  
Criterion validity  Assesses the ability of a tool to 
detect what it is intended to 
detect by comparing it to a gold 
standard procedure.  
Comparison of GLIM’s 
identification of malnutrition to 
the identification obtained using 
a gold standard procedure. 
Predictive validity  Assesses the ability of the tool 
to predict future outcomes 
expected to be associated with 
the construct.  
E.g. mortality and LOS, which 
are known to be associated 
with malnutrition.   
Abbreviations: GLIM, Global Leadership Initiative on Malnutrition; LOS, length of stay.  
 
1.11. Clinical relevancy statement 
It is well established that malnutrition is prevalent in hospitalized patients, adversely affecting 
patient health outcomes and healthcare utilization. Still, clinical practice and nutrition 
research is limited by a lack of universally accepted diagnostic criteria. The newly published 
GLIM criteria provide a globally accepted approach to define malnutrition across care 
settings. As the proposed GLIM criteria are consensus based, they need to be applied to 
clinical practice for validation and further improvement (4, 62). Currently, the literature on 
the GLIM criteria’s diagnostic accuracy is scarce. 
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2. Study aims 
 
2.1. Primary aims 
- To investigate the GLIM criteria’s criterion validity in a hospital setting when 
compared to the ICD-10.  
- To investigate the prevalence of malnutrition among hospitalized patients at HUH 
according to the GLIM criteria and ICD-10.  
 
2.2. Secondary aim 
- To investigate which diagnostic criteria contribute most to the GLIM and ICD-10 




H0:  GLIM has satisfactory criterion validity for the diagnosis of malnutrition and agrees 
with the ICD-10 diagnostic codes E.44.0 and E.43.  
 
HA:  GLIM has unsatisfactory criterion validity for the diagnosis of malnutrition and is not 
in agreement with the ICD-10 diagnostic codes E.44.0 and E.43. 
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3. Materials and methods  
3.1. Study design  
The present study is a cross-sectional analysis of data collected from the matched cohort study 
called the MALNUTRA-study. The MALNUTRA-study was conducted from September 
2017 to December 2019, as a collaboration between Haukeland University Hospital (HUH) 
and the University of Bergen, aiming to assess determinants and consequences of 
malnutrition. The present study is conducted at the Department of Clinical Science, 
University of Bergen, as part of the ongoing MALNUTRA-project.   
 
Sections 3.2-3.3 will describe MALNUTRA study procedures carried out by study personnel, 
with relevance for this thesis.  
 
3.2. MALNUTRA study population and recruitment process 
The MALNUTRA study population consists of inpatients mainly from the Department of 
Thoracic Medicine and Heart Disease, the Departments of Dermatology/ Rheumatology, 
Internal Medicine (Gastroenterology and Endocrinology), and the Orthopedic Clinic. In brief, 
the study population was recruited following a matched cohort design. Patients at nutritional 
risk (“at risk”) and patients not at nutritional risk (“not at risk”) were matched for age (+/- 10 
years), gender and diagnosis. Eligible at risk patients and suitable not at risk matches were 
asked to participate based on criteria described in Table 6. The same eligibility and exclusion 
criteria were extended onto the current thesis, with the added criteria that all participants had 
to have anthropometrical and nutritional data on at least one phenotypic and etiologic GLIM 












Table 6. Eligibility and exclusion criteria used in the MALNUTRA recruitment process.  
Eligibility criteria  Exclusion criteria 
Age ≥ 18 years Current cancer diagnosis  
Nutritional risk assessed using NRS-2002 Patients from intensive care unit 
Understanding the Norwegian language Patients with transmissible infectious disease 
Cognitive abilities to understand the study 
purposes 
Insufficient data for GLIM assessment a 
Time to participate in the additional 
measurements 
 
Willingness to participate  
 
a Additional exclusion criteria for the current thesis, and not used in the original MALNUTRA recruitment process.  
Abbreviations: NRS-2002, Nutritional Risk Screening 2002; GLIM, Global Leadership Initiative on Malnutrition.  
 
3.3. MALNUTRA data collection  
3.3.1. The MALNUTRA screening-procedure 
Information regarding patient nutritional risk status was obtained from the medical journal 
Distribuert Informasjons og Pasientdatasystem (DIPS). The study procedures then included a 
re-screening by the study personnel, also using NRS-2002. The study re-screening used 
measured weight and height, information on weight history and food intake from a study 
questionnaire (Appendix I), and information on diagnosis from the discharge letters in the 
medical records. Information on length of stay at the ward was also extracted from the 
patients discharge letters. Anthropometrical measurements and data for nutritional assessment 
in the present thesis, are further elaborated below.  
 
3.3.2. Anthropometrical measurements.  
All anthropometrical measurements were collected in the patient room according to standard 
operating procedures (SOPs), while the patients were in hospital clothes without shoes. 
Weight was measured once in kilograms using a portable flat scale, Seca model 877 
(Hamburg, Germany). Height was measured twice in centimeters at maximal inspiration using 
a portable stadiometer, Seca model 217 (Hamburg, Germany). The mean value was used for 
further analysis. If height measurements could not be conducted, self-reported height was 
used. Skinfold thickness (measured in millimeters) was measured three times using a Lange 
skinfold caliper (Santa Cruz, USA). The mean value was used for further analysis. Mid upper 
arm circumference (measured in centimeters) was measured twice using a non-elastic 
ergonomic measuring tape, Seca model 201 (Hamburg, Germany). Each measurement was 
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noted at the nearest 0.1 centimeter, and the mean value of the two measurements was used for 
further analysis. For further detail regarding the execution of the anthropometrical 
measurements, see SOPs listed in Appendix II-V.  
 
3.3.3. Weight history and food intake 
During the re-screening procedure, the patients were asked to answer a general questionnaire, 
called the MALNUTRA- questionnaire. The MALNUTRA- questionnaire was made 
specifically for the study and contained questions regarding health, lifestyle and social factors 
Page 1 (see Appendix I) contained questions regarding weight history and food intake, which 
was used in the present thesis for the diagnostic assessment of malnutrition as described in 
section 3.4.  
 
3.3.4. Blood samples 
Biochemical and haematological parameters including serum C-reactive protein (CRP) were 
measured usually from morning blood samples and analysed at the central laboratory at the 
Haukeland University Hospital using standard methods.  
 
3.4. Diagnostic assessment of Malnutrition  
3.4.1. Data collection from the MALNUTRA-database 
For the assessment of malnutrition using ICD-10 and GLIM as diagnostic tools, the following 
data were extracted from the MALNUTRA- database: Height, weight, BMI, self-reported 
weight loss the last 3 months, self-reported food intake the last week, skinfold thickness 
(SFT), mid-upper arm circumference (MUAC) and serum CRP. BMI was calculated using the 
formula: BMI= bodyweight in kg/ (height in m)2. Weight loss was reported in kilograms, and 
percentage weight loss was calculated based on measured weight during the study re-
screening using the formula: [(Weight loss in kg/ (Measured weight in kg + weight loss in kg) 
*100) = Weight loss in percent]. Mid arm muscle circumference (MAMC) was calculated 
using the formula: MUAC- (3.14 x SFT x 0.1).  
 
3.4.2. Diagnostic procedure   
Based on the information extracted from the MALNUTRA-database, diagnostic assessment 
of malnutrition was conducted as illustrated in Figure 3. The assessment was carried out 
blinded for patient nutritional risk status. The whole set of patients were assessed using GLIM 
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criteria first, before re-assessing using the ICD-10 criteria while blinded to the outcome of the 
GLIM assessment.  
 
Figure 3. Flow chart over the GLIM and ICD-10 diagnostic assessment process.  
 
3.4.2.1. GLIM diagnostic assessment 
The GLIM criteria were applied based on available data from the MALNUTRA- database. 
For the diagnosis of I. GLIM Malnutrition, II. GLIM Stage 1. Moderate malnutrition, or III. 
GLIM Stage 2. Severe malnutrition, the phenotypic and etiologic criteria presented in Table 7 
were used. Calculations of MAMC were used in the assessment of the phenotypic criteria of 
reduced muscle mass. The cut-off points applied (63) are presented in Table 8. For the 
etiologic criteria, presence of inflammation was defined as CRP ≥ 5, and reduced food intake 
was defined as < 50% of ER last week based on answers from the MALNUTRA-
questionnaire (Appendix I) where “less than half of normal” was interpreted as < 50% of ER 
and “less than a quarter of normal” was interpreted as < 25% of ER. 
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Table 7. Phenotypic and etiologic criteria applied in the assessment process for the GLIM diagnosis of malnutrition, with thresholds for severity 
grading into Stage 1. Moderate and Stage 2. Severe Malnutrition.  
 
 Phenotypic Criteria Etiologic Criteria 
 Weight loss (%) Low body mass 
index (kg/m2) 
Reduced muscle mass c Reduced food intake d Inflammation 
Malnutrition a >5% within past 
3 months 
<20 if <70 years 
or < 22 if > 70 
years 
Any reduction in MAMC below 
10th or 5th percentile c 
<50% of ER > 1 week d CRP ≥ 5 mg/dl 
Stage 1. Moderate 
Malnutrition b  
5-10% within 
past 3 months 
<20 if <70 years 
or < 22 if > 70 
years 




Stage 2. Severe 
Malnutrition b  
>10% within 
past 3 months  
<18,5 if <70 
years or < 20 if 
> 70 years 




a At least 1 phenotypic criterion and 1 etiologic criterion was required for the diagnosis of malnutrition. 
b Severity grading was based upon the most severe phenotypic criteria.  
c MAMC cut-off points used to assess reduced muscle mass are presented in Table 8.  
d Data on food intake was based on self-reported answers from the MALNUTRA-questionnaire (Appendix I).  
Abbreviations: GLIM, Global Leadership Initiative on Malnutrition; MAMC, mid arm muscle circumference; ER, estimated requirements; CRP, C-reactive protein.  
 
 
Table 8. Mid arm muscle circumference (MAMC) cutoff points in centimeters, used for GLIM malnutrition assessment. From (63).  
 
Sex Age Moderate malnutrition  
(10th percentile) a 
Severe malnutrition  
(5th percentile) a 
Women 20-79 19 18  
 80-89 18 17 
Men 20-79 23 22 
 80-89 21 20 
a Values in cm.  
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Patients were categorized as malnourished by GLIM if at least one phenotypic and one 
etiologic criterion were met. The category “GLIM malnourished” was created in order to 
provide a dichotomous response for analysis, and includes all patients identified as 
malnourished by GLIM prior to severity grading. The GLIM criteria combinations used for 
the diagnosis of malnutrition were A) Weight loss and reduced food intake B) Weight loss 
and inflammation C) Low BMI and reduced food intake D) Low BMI and inflammation E) 
Reduced muscle mass and reduced food intake F) Reduced muscle mass and inflammation 
(Figure 4). If a patient met more than one phenotypic criterion, the most severe criterion was 
used. If a patient met more than one equally severe phenotypic criterion, e.g. severely low 
BMI and muscle mass, the diagnosis was based on the prioritized order of 1) Low BMI 2) 
Weight loss 3) Reduced muscle mass. If a patient met more than one etiologic criterion, 
diagnosis was based on the prioritized order of 1) Reduced food intake and 2) inflammation. 
After selecting the most appropriate GLIM criteria combination, patients were categorized as 
moderately or severely malnourished based on the selected phenotypic criterion.  
 
 
Figure 4. GLIM criteria combinations used for diagnostic assessment of malnutrition.  
A) weight loss and reduced food intake B) weight loss and inflammation C) low BMI and 
reduced food intake D) low BMI and inflammation E) reduced muscle mass and reduced food 





3.4.2.2. ICD-10 diagnostic assessment 
Criteria for the ICD-10 malnutrition diagnoses E.44.0 and E.43 were then applied based on 
available data from the MALNUTRA-database. For further analysis, ICD-10 E.44.0. 
Moderate protein-/energy malnutrition will be referred to as “ICD-10 moderate malnutrition”, 
and ICD-10 E.43 Severe protein-/energy malnutrition as “ICD-10 severe malnutrition”. The 
criteria presented in Table 9 were used for the diagnosis of 1) ICD-10 moderate malnutrition, 
or 2) ICD-10 severe malnutrition. As with GLIM, an extra category called “ICD-10 
malnourished” was created, including all patients identified as moderately or severely 
malnourished by ICD-10. If a patient met more than one criterion, the most severe criterion 
was used. If a patient met more than one equally severe criterion, the diagnosis was given 
based on a prioritized order of 1) Low BMI 2) Weight loss 3) Low BMI and weight loss 4) 
Reduced food intake.  
 
Table 9. Criteria applied in the nutritional assessment process for the ICD-10 diagnoses of 
moderate (E.44.0) and severe (E.43) malnutrition.  
 
Code Term Criteria a 
  Weight 
loss (%) 
Low body mass 
index (kg/m2) 
Low body mass index 





malnutrition   
> 10% last 
3 months 
< 18.5 if < 70 
years or < 20 if 
>70 years 
< 20.5 (< 22 if > 70 
years) and weight loss 
> 5% last 3 months 
< 50% of ER 
last week 
E.43 ICD-10 Severe 
malnutrition  
> 15% last 
3 months 
< 16 if < 70 
years or < 18.5 
if >70 years 
< 18.5 (< 20 if > 70 
years) and weight loss 
> 5% last 3 months 
N/A 
 
a Requires at least 1 criterion for diagnosis.  
Abbreviations: ICD-10, International Classification of Diseases 10th edition; N/A, not available; ER, estimated 
requirements.  
 
3.4.2.3. Nutritional risk assessment 
Lastly, the NRS-2002 score from the re-screening (see Section 3.3.1) was used to determine 
patient nutritional risk status. Patients were categorized as being at nutritional risk if the NRS-
2002 score ≥ 3. Nutritional risk corresponds to ICD-10 E.46 Unspecified protein-/energy 
malnutrition, which will be referred to as “Nutritional risk” in further analysis and considered 
separate from the ICD-10 malnutrition diagnoses described in Section 3.4.2.2.  
 
3.5. Ethical considerations 
The MALNUTRA study protocols were approved by the Regional Ethical Committee (REC 
number 2016/792) and conducted according to the Declaration of Helsinki ethical principles 
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for medical research (64). All participants received verbal or written information regarding 
the study, and informed consent was obtained before participation. In order to secure patient 
privacy, personal data were pseudo- anonymized and stored at a research sever with restricted 
access only for authorized study personnel. The ID-key was stored in a separate location on 
the research server, only accessible to the project leader.  
 
3.6. Statistical analysis 
All analyses were performed using IBM SPSS statistics version 26 (IBM corp., Armonk, NY, 
USA). A p-value of less than 0.05 was considered significant.  
 
3.6.1. Descriptive statistics 
Continuous variables were presented as mean and standard deviation (SD) when normally 
distributed, or as median and interquartile range (IQR) if non-normally distributed. The 
normality of the data was analyzed using the Shapiro-Wilk test. Categorical variables were 
presented as numbers and percentages. The Chi-square test was used to compare categorical 
variables, and the independent samples t-test or the Mann Whitney U-test were used for 
quantitative variables.  
 
3.6.2. Validity and agreement statistics 
In order to validate the GLIM criteria, validity statistics were performed using ICD-10 as a 
“semi-gold standard” for detecting the presence and severity of malnutrition. First, the 
proportion of patients identified as malnourished by each tool was calculated. Then sensitivity 
(Se), specificity (Sp), negative predictive values (NPVs) and positive predictive values 
(PPVs) were calculated. In order to rate the outcome, the following cut-off values were 
applied (65): “Good”, Se AND Sp > 80%; “Fair”, Se OR Sp > 80%, but both > 50%; “Poor”, 
Se OR Sp < 50%. Cohen’s kappa (κ) was used to measure agreement between ICD-10 and 
GLIM as diagnostic tools. In order to rate the strength of agreement, cutoff values for 
Cohen’s kappa (κ) were applied (66, 67): “Poor”, 0.0-0.2; “Fair”, 0.21-0.40; “Moderate”, 
0.41-0.60; “Good”, 0.61-0.80; “Very good”, 0.81-1.00. 
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4. Results  
4.1. General population characteristics 
Out of 992 patients asked to participate in the MALNUTRA-study, a total of 326 patients 
(approximately 33%) were included in the current study. Patients who declined participation 
were 55% women with a median age of 79 years, and the men were at median 75 years old. 
Reasons for non-participation, exclusion and withdrawal are listed in the flow chart below 
(Figure 5). 
 
Figure 5. Flow chart over participant inclusion and exclusion process. 
 
Of the included patients, 53% were men and the median age of inclusion was 71 years (IQR 
18). Most patients were from the Department of Thoracic medicine (n=136; 42%) and the 
Department of Heart disease (n=110; 34%), while the remainder (n=80; 25%) were from the 
departments of Gastroenterology, Endocrinology, Dermatology and Rheumatology, and the 
orthopedic clinic. Median length of stay at the ward was 7 days (IQR 8) and the patients had a 
median of 3 diagnoses (IQR 2) reported in their medical records.  
 
Of the parameters used to assess nutritional status, some information was missing. 
Information on bodyweight and BMI was available for 322 patients (98.7%), MAMC could 
be calculated based on MUAC and SFT measured in 304 patients (93.3%), CRP was available 
for 323 patients (99.1%), information on food intake the last week was reported by 302 
patients (92.6%), and information on weight loss was reported by 306 patients (93.9%).  





Included in the present 
study
N = 326
Non-responders N = 642
- Unwilling N = 240
- Feeling unwell/study too demanding N = 286
- Discharge same day N = 83
- Problems with hearing/reading/writing N = 18
- Not eligible N = 8
- Occupied with procedures/student examinations N = 5
- Already participated in the study N = 2
Excluded N = 24
- Missing NRS2002-score N = 9
- Missing questionnaire for re-screening N = 3
- Not eligible for GLIM nutritional assessment N = 2
- Cognitive impairment N = 4
- Cancer treatment N = 1
- Pregnant N = 2
- Withdrew consent N = 1
- Included twice N = 1
- Severe exacerbation of illness N = 1
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4.2. Comparison of patients according to nutritional status  
4.2.1. Nutritional risk 
Of the total population, 142 (43.6%) were identified as being at nutritional risk and 184 
(56.4%) as not being at nutritional risk based on the re-screening using NRS-2002. Full 
patient characteristics according to nutritional risk status are presented in Table 10. The 
patients at nutritional risk were older (median age 74 vs. 68 years) and had longer length of 
stay at the ward (median 8 vs. 7 days) when compared to patients not at risk. Distribution 
based on sex was even, with 50% women of patients categorized to be at nutritional risk, and 
45% women among the patients not at risk. Patients from both categories had median 3 
diagnoses in total. Patients at nutritional risk had lower bodyweight (median 63 vs. 78 kg), 
lower BMI (median 23 vs. 27 kg/m2) and reported weight loss above 5,10 and 15% for the 
last 3 months was consistently higher compared to patients not at risk. Among the patients at 
nutritional risk, 28% (n=52) reported a food intake below half of the ER last week, compared 
to 5% (n=7) of the patients not at risk. When considering the nutritional indicators not 
incorporated in NRS-2002, patients at nutritional risk had lower muscle mass as assessed by 
MAMC (median 21 vs. 24 cm), and a higher degree of inflammation as assessed by CRP 
(median 22 vs. 12 mg/dl) when compared to patients not at risk. 
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  N (%) N (%) N (%)  
Total   326 (100) 142 (100) 184 (100)  
Sex     
 Women 153 (47) 71 (50) 82 (45) 0.330 f 
Departments     
 Heart Disease 110 (34) 40 (28) 70 (38)  
 Thoracic Medicine 136 (42) 68 (48) 68 (37)  
 Others a 80 (25) 34 (24) 46 (25)  
  Median (IQR) Median (IQR) Median (IQR)  
Age, years  71 (18) 74 (16) 68 (18) 0.000 
Length of stay, days 7 (8) 8 (9) 7 (7) 0.016 
Diagnoses, number 3 (2) 3 (3) 3 (3) 0.000 
BMI, kg/m2 b 25 (7) 23 (6) 27 (7) 0.000 
Bodyweight, kg b 71 (22) 63 (18) 78 (19) 0.000 
MAMC, cm c  23 (5) 21 (4) 24 (5) 0.000 
CRP, mg/L d 15 (45) 22 (69) 12 (34) 0.001 
 N (%) N (%) N (%)  
Low food intake e 59 (18) 52 (28) 7 (5) 0.000 f 
Weight loss f     
 >5% 68 (21) 53 (29) 15 (11) 0.181 f 
 >10% 36 (11) 27 (15) 9 (6) 0.921 f 
 >15% 13 (4) 12 (7) 1 (1) 0.110 f 
 
a Departments of Gastroenterology, Endocrinology, Dermatology and Rheumatology, and the Orthopedic Clinic.  
b n=322 patients with information on BMI and bodyweight. 
c n= 304 patients with information on MAMC. 
d n=323 patients with information on CRP.  
e n= 302 patients with information on food intake, low food intake was defined as < 50% of ER the last week. 
f n=306 patients with information on weight loss the last 3 months.  
g P-value is calculated using Mann-Whitney U-test for nonparametric independent samples, significance level: p < 0.05 
h P-value is calculated using Pearson’s chi-square test, significance level: p < 0.05 
Abbreviations: NRS-2002, Nutritional Risk Screening 2002; BMI, Body mass index; MAMC, Mid arm muscle circumference; 
CRP, C-reactive protein; IQR, Interquartile range; ER, estimated requirements.  
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4.2.2. Malnourished according to ICD-10.  
In the retrospective application of the ICD-10 codes E.44.0 and E.43, 122 (37.4%) were 
identified as being malnourished, and 204 (62.6%) as well-nourished. Full population 
characteristics according to the nutritional assessment using ICD-10 are presented in Table 
11. There was no difference in age (median 71 vs. 71 years), LOS (median 3 vs. 3 days), 
number of diagnoses (median 3 vs. 3 diagnoses in total) and distribution based on sex (49% 
vs. 46% women) between malnourished and well-nourished, respectively. Almost half of the 
malnourished patients (n=60) were from The Department of Thoracic Medicine, while the 
remaining half was evenly distributed between the Department of Heart Disease (n=26) and 
the Departments of Gastroenterology, Endocrinology, Dermatology and Rheumatology, and 
the Orthopedic Clinic (n=30). The malnourished patients had lower bodyweight (median 61 
vs. 76 kg), a higher weight loss the last 3 months (median 6 vs. 3 kg) lower BMI (median 21 
vs. 27 kg/m2), lower muscle mass as assessed by MAMC (median 21 vs. 23 cm), and a higher 
degree of inflammation as assessed by CRP (median 17 vs. 13 mg/dl) when compared to the 
well-nourished. Of the malnourished patients, 48% (n=58) reported having a food intake 
below half of the ER the last week, while less than 1% (n=1) of the well-nourished reported 
the same. 
 
Malnourished patients were further grouped as moderately (E.44.0) and severely (E.43) 
malnourished. Of the total population, 28% (n=91) were identified as moderately 
malnourished and 9.5% (n=31) as severely malnourished using ICD-10. There was no 
difference in number of diagnoses (median 3 vs. 3 diagnoses in total) and in distribution based 
on sex (50% vs. 48% women) between the moderately and severely malnourished patients, 
respectively. The severely malnourished patients were older (median 73 vs. 68 years) and had 
a shorter LOS (median 7 vs. 8 days) when compared to the moderately malnourished. The 
Department of Thoracic Medicine had the most moderately (n=41) and severely (n=19) 
malnourished patients. The severely malnourished patients had lower bodyweight (median 52 
vs. 66 kg), larger weight loss the last 3 months (median 9 vs. 6 kg) lower BMI (median 18 vs. 
23 kg/m2), and lower muscle mass as assessed by MAMC (median 20 vs. 22 cm) when 
compared to the moderately malnourished. There was a higher degree of inflammation in the 
moderately malnourished compared to the severely malnourished, as assessed by CRP 
(median 18 vs. 15 mg/dl). Of the moderately malnourished patients, 56% (n=51) reported 
having a food intake below half of the ER the last week, while 23% (n=7) of the severely 
malnourished reported the same. 
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 No malnutrition Malnutrition P-value d Moderate Malnutrition Severe Malnutrition  P-value d 
  N (%) N (%)  N (%) N (%)  
Total  204 (100) 122 (100)  91 (100) 31 (100)  
Sex       
 Women 93 (46) 60 (49) 0.529 e 45 (50) 15 (48) 0.919 e 
Departments       
 Heart Disease 78 (38) 32 (26)  24 (26) 8 (26)  
 Thoracic Disease 76 (37) 60 (49)  41 (45) 19 (61)  
 Others a 50 (25) 30 (25)  26 (29) 4 (13)  
  Median (IQR) Median (IQR)  Median (IQR) Median (IQR)  
Age, years  71 (17) 71 (19) 0.850 68 (26) 73 (11) 0.195 
Length of stay, days 7 (8) 7 (8) 0.586 8 (7) 7 (8) 0.800 
Diagnoses, number 3 (2) 3 (2) 0.117 3 (2) 3 (3) 0.328 
BMI, kg/m2  27 (7) 21 (6) 0.000 23 (6) 18 (3) 0.000 
Bodyweight, kg 76 (21) 61 (19) 0.000 66 (18) 52 (11) 0.000 
Weight loss, kg b 3 (3) 6 (6) 0.000 6 (5) 9 (8) 0.030 
MAMC, cm 23 (5) 21 (4) 0.000 22 (4) 20 (3) 0.000 
CRP, mg/L 13 (41) 17 (66) 0.076 18 (92) 15 (51) 0.426 
 N (%) N (%)  N (%) N (%)  
Low food intake c 1 (<1) 58 (48) 0.000 e 51 (56) 7 (23) 0.001 e 
 
a Departments of Gastroenterology, Endocrinology, Dermatology and Rheumatology, and the Orthopedic Clinic.  
b Weight loss the last 3 months.  
c Low food intake defined as < 50% of ER 
d P-value is calculated using Mann-Whitney U-test for nonparametric independent samples, significance level: p < 0.05 
e P-value is calculated using Pearson’s chi-square test, significance level: p < 0.05 
Abbreviations: ICD-10, International Classification of Diseases 10th edition.; BMI, Body mass index; MAMC, Mid arm muscle circumference; CRP, C-reactive protein; IQR, Interquartile 
range; ER, estimated requirements.
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4.2.3. Malnourished according to the GLIM criteria.  
In the retrospective application of the GLIM criteria, 114 (34.9%) were identified as being 
malnourished, and 212 (65.0%) as well-nourished by GLIM. For the category of 
malnourished, moderately and severely malnourished patients were grouped. Full population 
characteristics according to the nutritional assessment by GLIM are presented in Table 12. 
There was no difference in age (median 72 vs. 70 years) and number of diagnoses (median 3 
vs. 3 diagnoses in total) between malnourished and well-nourished, respectively. 
Malnourished patients had one day longer length of stay at the ward (median 8 vs. 7 days) and 
consisted of fewer women (37% vs. 52% women) when compared to the well-nourished 
patients. Half of all malnourished patients (n=57) were from The Department of Thoracic 
Medicine, followed by the Department of Heart Disease (n=35) and the Departments of 
Gastroenterology, Endocrinology, Dermatology and Rheumatology, and the Orthopedic 
Clinic (n=22). The malnourished patients had lower bodyweight (median 64 vs. 76 kg), larger 
weight loss the last 3 months (median 6 vs. 5 kg) lower BMI (median 21 vs. 27 kg/m2), lower 
muscle mass as assessed by MAMC (median 21 vs. 24 cm), and a higher degree of 
inflammation as assessed by CRP (median 28 vs. 11 mg/dl) when compared to the well-
nourished. Of the malnourished patients, 26% (n=30) reported having a food intake below 
half of the ER the last week, while less than 14% (n=29) of the well-nourished reported the 
same. 
 
GLIM identified 12.6% (n=41) as moderately malnourished and 22.4% (n=73) as severely 
malnourished. There was no difference in age (median 69 vs. 72 years), distribution based on 
sex (39% vs. 36% women, or length of stay at the ward (median 8 vs. 8 days) between the 
moderately and severely malnourished patients, respectively. The severely malnourished 
patients had more diagnoses in total (median 4 vs. 3) when compared to the moderately 
malnourished. The Department of Thoracic Medicine had the most moderately (n=19) and 
severely (n=38) malnourished patients. The severely malnourished patients had lower 
bodyweight (median 59 vs. 69 kg), larger weight loss the last 3 months (median 8 vs. 5 kg) 
lower BMI (median 20 vs. 23 kg/m2), and lower muscle mass as assessed by MAMC (median 
20 vs. 22 cm) when compared to the moderately malnourished. The degree of inflammation as 
assessed by CRP was similar in the moderately malnourished compared to the severely 
malnourished (median 29 vs. 28 mg/dl). Of the moderately malnourished patients, 34% 
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(n=14) reported having a food intake below half of the ER the last week, while 22% (n=16) of 
the severely malnourished reported the same. 
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Table 12. Patient characteristics according to nutritional status assessed by GLIM.  
 
  No malnutrition Malnutrition P-value d Moderate malnutrition Severe malnutrition P-value d 
  N (%) N (%)  N (%) N (%)  
Total  212 (100) 114 (100)  41 (100) 73 (100)  
Sex       
 Women 111 (52) 42 (37) 0.007 e 16 (39) 26 (36) 0.717 e 
Departments       
 Heart Disease 75 (35) 35 (31)  14 (34) 21 (29)  
 Thoracic Disease 79 (37) 57 (50)  19 (46) 38 (52)  
 Others a 58 (27) 22 (19)  8 (20) 14 (19)  
  Median (IQR) Median (IQR)  Median (IQR) Median (IQR)  
Age, years  70 (20) 72 (14) 0.307 69 (12) 72 (15) 0.207 
Length of stay, days 7 (8) 8 (9) 0.041 8 (11) 8 (8) 0.794 
Diagnoses, number 3 (2) 3 (3) 0.000 3 (2) 4 (2) 0.018 
BMI, kg/m2 27 (6) 21 (5) 0.000 23 (5) 20 (4) 0.000 
Bodyweight, kg 76 (21) 64 (17) 0.000 69 (17) 59 (17) 0.000 
Weight loss, kg b 5 (6) 6 (6) 0.052 5 (2) 8 (6) 0.011 
MAMC, cm 24 (5) 21 (4) 0.000 22 (4) 20 (3) 0.000 
CRP, mg/L 11 (40) 28 (76) 0.000 28 (95) 29 (61) 0.820 
 N (%) N (%)  N (%) N (%)  
Low food intake c 29 (14) 30 (26) 0.012 e 14 (34) 16 (22) 0.156 e 
 
a Departments of Gastroenterology, Endocrinology, Dermatology and Rheumatology, and the Orthopedic Clinic.  
b Weight loss the last 3 months.  
c Low food intake defined as < 50% of ER 
d P-value is calculated using Mann-Whitney U-test for nonparametric independent samples, significance level: p < 0.05 
e P-value is calculated using Pearson’s chi-square test, significance level: p < 0.05 




4.2.4. Combinations of GLIM and ICD-10 malnourished 
ICD-10 identified 50 patients (15.3%) as malnourished, which GLIM identified as well-
nourished. Likewise, GLIM identified 42 patients (12.8%) as malnourished which ICD-10 
identified as well-nourished. Full population characteristics according to the nutritional 
assessment by GLIM and ICD-10 are presented in Table 13. The patients identified as both 
malnourished by GLIM and well-nourished by ICD-10 were older (72 vs. 67 years), consisted 
of fewer women (12% vs. 30% women), had longer length of stay at the ward (9 vs. 7 days), 
and more diagnoses (3 vs. 2 diagnoses in total), when compared to the patients identified as 
both malnourished by ICD-10 and well-nourished by GLIM. Furthermore, the patients 
identified as both GLIM malnourished and ICD-10 well-nourished had higher bodyweight 
(median 69 vs. 67 kg), lower weight loss the last 3 months (median 5 vs. 6 kg) lower BMI 
(median 23 vs. 24 kg/m2), lower muscle mass as assessed by MAMC (median 21 vs. 22 cm), 
and a higher degree of inflammation as assessed by CRP (median 27 vs. 5 mg/dl) when 
compared to patients identified as both ICD-10 malnourished and GLIM well-nourished. Of 
the patients identified as both malnourished by ICD-10 and well-nourished by GLIM, 58% 
(n=29) reported having a food intake below half of the ER the last week. This was not 




Table 13. Patient characteristics according to nutritional status assessed by GLIM and ICD-
10.  
 
  ICD-10 malnourished and   
and GLIM well-nourished  
GLIM malnourished and 
ICD-10 well-nourished 
  N (%) N (%) 
Total  50 (100) 42 (100) 
Sex   
 Women 30 (60) 12 (29) 
Departments   
 Heart Disease 14 (28) 17 (41) 
 Thoracic Disease 20 (40) 17 (41) 
 Others a 16 (32) 8 (19) 
  Median (IQR) Median (IQR) 
Age, years  67 (28) 72 (13) 
Length of stay, days 7 (8) 9 (10) 
Diagnosis, number 2 (1) 3 (2) 
BMI, kg/m2 24 (6) 23 (5) 
Bodyweight, kg 67 (22) 69 (15) 
Weight loss, kg b 6 (7) 5 (3) 
MAMC, cm 22 (5) 21 (3) 
CRP, mg/L 5 (38) 27 (58) 
 N (%) N (%) 
Low food intake c 29 (58) 0 (0) 
 
a Departments of Gastroenterology, Endocrinology, Dermatology and Rheumatology, and the Orthopedic Clinic.  
b Weight loss the last 3 months.  
c Low food intake defined as < 50% of ER 
Abbreviations: GLIM, Global Leadership Initiative on Malnutrition; ICD-10, International Classification of Diseases 10th 























4.3. GLIM criteria combinations  
For the diagnosis of malnutrition, GLIM requires at least one phenotypic and etiologic criteria 
be present. The GLIM criteria combinations used to support the 114 malnutrition diagnoses 
are presented in Figure 6.  
 
 
Figure 6. Distribution of GLIM combinations (A-F) of phenotypic and etiologic criteria used 
to support the diagnosis of malnutrition. A) Weight loss and reduced food intake B) Weight 
loss and inflammation C) Low BMI and reduced food intake D) Low BMI and inflammation 
E) Reduced muscle mass and reduced food intake F) Reduced muscle mass and inflammation.  
 
From most to least frequent, the combinations used for diagnosis were: D “low BMI and 
inflammation” 30.7% (n=35); F “reduced muscle mass and inflammation” 26.3% (n=30); B 
“weight loss and inflammation” 17.5% (n=20); C “low BMI and reduced food intake” 10.5% 
(n=12); A “weight loss and reduced food intake” 8.8% (n=10); E “reduced muscle mass and 
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4.4. Diagnostic criteria for moderate and severe malnutrition  
The diagnostic criteria used to support a malnutrition diagnosis when retrospectively applying 




Figure 7. Distribution of criteria used to diagnose a) ICD-10 moderate malnutrition (E.44.0), 
b) ICD-10 severe malnutrition (E.43), and distribution of phenotypic criteria used to 
categorize GLIM-defined malnutrition into c) Stage 1 moderate malnutrition, and d) Stage 2 
severe malnutrition.  
 
In the ICD-10 moderately malnourished (E.44.0) patients, diagnosis was based according to 
the criterion for reduced food intake in 48% (n=44), low BMI in 21% (n=19), weight loss in 
21% (n=19), and low BMI and weight loss in 10% (n=9), In the ICD-10 severely 
malnourished (E.43) patients, diagnosis was based on the criterion for low BMI in 55% 
(n=17), weight loss in 29% (n=9), and weight loss and low BMI in 16% (n=5). 
 
In the GLIM malnourished patients, the severity grading for moderate malnutrition was based 
on the phenotypic criteria of low BMI in 22.7% (n=74) of patients, weight loss in 9.8% 
(n=32), and reduced muscle mass identified in 8.6% (n=28) of patients. As for GLIM severely 
malnourished, severity grading was based on the phenotypic criterion of reduced muscle mass 
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In 104 cases an ICD-10 malnutrition diagnosis was based on solely one criteria of the most 
severe degree. 13 patients met two equally severe diagnostic criteria, and 4 patients met three 
equally severe diagnostic criteria. As per GLIM, 83 patients met only one phenotypic criterion 
of equal severity, 47 patients met two, and 15 patients met three. As for the etiologic criteria, 
200 patients met one, and 52 patients met two.  
 
4.5. Prevalence of nutritional risk and malnutrition  
The prevalence of nutritional risk as per NRS-2002 was 44% (n=142). Table 14 shows the 
proportion of patients identified as at nutritional risk by the screening, and the proportion of 
at- risk patients who were identified by GLIM and ICD-10 as malnourished. Out of the 
patients identified as being at nutritional risk GLIM identified 54% (n=77) as malnourished, 
of which 14% (n=20) was moderately and 40% (n=57) was severely malnourished. Likewise, 
ICD-10 identified 73% (n=104) of the at-risk patients as being malnourished, of which 54 % 




Table 14. Number of patients identified as being in nutritional risk by NRS-2002 and 
malnourished, moderately malnourished or severely malnourished by GLIM and ICD-10.  
 
 Nutritional Risk a  
 Yes No Total, N (%) 
GLIM Malnutrition b    
 Yes 77 37 114 (35) 
 No 65 147 212 (65) 
     
GLIM Moderate Malnutrition     
 Yes 20 21 41 (13) 
 No 122 163 285 (87) 
     
GLIM Severe Malnutrition     
 Yes 57 16 73 (22) 
 No 85 168 253 (78) 
     
Total, N (%) 142 (44) 184 (56) 326 (100) 
    
 
 Nutritional Risk a  
 Yes No Total, N (%) 
ICD-10 Malnutrition c    
 Yes 104 18 122 (37) 
 No 38 166 204 (63) 
     
ICD-10 Moderate Malnutrition    
 Yes 77 14 91 (28) 
 No 65 170 235 (72) 
     
ICD-10 Severe Malnutrition     
 Yes 27 4 31 (9.5) 
 No 115 180 295 (90.5) 
     
Total, N (%) 142 (44) 184 (56) 326 (100) 
    
 
a Patients with a total NRS-2002 score ≥ 3 were classified as at nutritional risk. 
a Patients were classified as malnourished by GLIM if at least one phenotypic and one etiologic criterion were met; 
moderately malnourished if at least one moderate phenotypic criterion and one etiologic criterion were met; and severely 
malnourished if at least one severe phenotypic criterion and one etiologic criterion were met (Table 7).  
b Patients were classified as malnourished by ICD-10 if at least one criterion for moderate protein-/energy malnutrition 
(E.44.0) or severe protein-/energy malnutrition (E.43) were met; moderately malnourished if at least one criterion for 
moderate protein-/energy malnutrition (E.44.0) were met; or severely malnourished if at least one criterion for severe protein-
/energy malnutrition (E.43) were met (Table 9).  
Abbreviations: NRS-2002, Nutritional Risk Screening 2002; GLIM, Global Leadership Initiative on Malnutrition; ICD-10, 
International Classification of Diseases 10th edition.  
 
 
Table 15 shows the proportion of patients identified as malnourished by both GLIM and ICD-
10, and those who were categorized as moderately or severely malnourished by GLIM and 
ICD-10. The prevalence of GLIM-defined malnutrition was 35% (n=114). Based on ICD-10 
the prevalence of malnutrition was 37% (n=122) GLIM identified 13% (n=41) as moderately 
malnourished, and 22% (n=73) as severely malnourished. ICD-10 identified 28% (n=91) as 




Table 15. Number of patients identified as being malnourished, moderately malnourished or 
severely malnourished by ICD-10 and GLIM.  
 
 ICD-10 Malnutrition a  
 Yes No Total, N (%) 
GLIM Malnutrition b    
 Yes 72 42 114 (35) 
 No 50 162 212 (65) 
 Total, N (%) 122 (37) 204 (63) 326 (100) 
     
  ICD-10 Moderate Malnutrition  
  Yes No Total, N (%) 
GLIM Moderate Malnutrition    
 Yes 17 24 41 (13) 
 No 74 211 285 (87) 
 Total, N (%) 91 (28) 235 (72) 326 (100) 
     
  ICD-10 Severe Malnutrition   
  Yes No Total, N (%) 
 GLIM Severe Malnutrition    
 Yes 27 46 73 (22) 
 No 4 249 253 (78) 
 Total, N (%) 31 (9.5) 295 (90.5) 326 (100) 
     
 
a Patients were classified as malnourished by GLIM if at least one phenotypic and one etiologic criterion were met; 
moderately malnourished if at least one moderate phenotypic criterion and one etiologic criterion were met; and severely 
malnourished if at least one severe phenotypic criterion and one etiologic criterion were met (Table 7).  
b Patients were classified as malnourished by ICD-10 if at least one criterion for moderate protein-/energy malnutrition 
(E.44.0) or severe protein-/energy malnutrition (E.43) were met; moderately malnourished if at least one criterion for 
moderate protein-/energy malnutrition (E.44.0) were met; or severely malnourished if at least one criterion for severe protein-
/energy malnutrition (E.43) were met (Table 9).  




4.6. Criterion validity of the GLIM criteria  
4.6.1. Sensitivity, specificity, NPV and PPV 
When comparing GLIM malnutrition to ICD-10 malnutrition based on the categories well-
nourished or malnourished, sensitivity (59.0%) and specificity (79.4%) was fair, the PPV was 
63.2% and the NPV was 76.4%. When comparing GLIM moderate malnutrition to ICD-10 
moderate malnutrition, based on the categories moderately malnourished or not, sensitivity 
(18.7%) and specificity (89.8%) was poor. PPV fell to 41.5% and NPV fell slightly to 74.0%. 
Lastly, comparing only GLIM severe malnutrition to ICD-10 severe malnutrition, based on 
the categories severely malnourished or not, sensitivity (87.1%) and specificity (84.4%) was 
good. PPV fell to 37.0% and NPV increased to 98.4%. All values of sensitivity, specificity, 




Table 16. Sensitivity, specificity, PPV and NPV of the GLIM-criteria for malnutrition, using 
ICD-10 as criterion.   
 
 GLIM Malnutrition a, c  
vs.  
ICD-10 Malnutrition b, c 
GLIM Moderate 
Malnutrition a, d  
vs.  
ICD-10 Moderate 
Malnutrition b, d 
GLIM Severe  
Malnutrition a, e  
vs.  
ICD-10 Severe  
Malnutrition b, e 
Sensitivity, % 59.0 18.7 87.1 
Specificity, % 79.4 89.8 84.4 
PPV, % 63.2 41.5 37.0 
NPV, % 76.4 74.0 98.4 
a Patients were classified as malnourished by GLIM if at least one phenotypic and one etiologic criterion were met; 
moderately malnourished if at least one moderate phenotypic criterion and one etiologic criterion were met; and severely 
malnourished if at least one severe phenotypic criterion and one etiologic criterion were met (Table 7).  
b Patients were classified as malnourished by ICD-10 if at least one criterion for moderate protein-/energy malnutrition 
(E.44.0) or severe protein-/energy malnutrition (E.43) were met; moderately malnourished if at least one criterion for 
moderate protein-/energy malnutrition (E.44.0) were met; or severely malnourished if at least one criterion for severe protein-
/energy malnutrition (E.43) were met (Table 9).  
c Categories: Not malnourished or malnourished (moderately and severely malnourished grouped).  
d Categories: Moderately malnourished or not moderately malnourished (well-nourished and severely malnourished grouped) 
e Categories: Severely malnourished or not severely malnourished (well-nourished and moderately malnourished grouped) 
Abbreviations: PPV, positive predictive value; NPV, negative predictive value; GLIM, Global Leadership Initiative on 
Malnutrition; ICD-10, International Classification of Diseases 10th edition.  
 
 
4.6.2. Agreement between GLIM and ICD-10  
Cohen’s kappa was calculated to determine if there was agreement between GLIM and ICD-
10 on which patients were malnourished, and further if there was agreement on which patients 
were moderately or severely malnourished. The results are presented in Table 17.  
 








error of κ 
P-value Strength of 
agreement 
GLIM Malnutrition a, c  
vs.  
ICD-10 Malnutrition b, c 
72 0.389 .053 .000 Fair 
GLIM Moderate Malnutrition a, d 
vs.  
ICD-10 Moderate Malnutrition b, d 
70 0.102 .054 .039 Poor 
GLIM Severe Malnutrition a, e  
vs.  
ICD-10 Severe Malnutrition b, e 
85 0.445 .062 .000 Moderate 
a Patients were classified as malnourished by GLIM if at least one phenotypic and one etiologic criterion were met; 
moderately malnourished if at least one moderate phenotypic criterion and one etiologic criterion were met; and severely 
malnourished if at least one severe phenotypic criterion and one etiologic criterion were met, according to Table 7.  
b Patients were classified as malnourished by ICD-10 if at least one criterion for moderate protein-/energy malnutrition 
(E.44.0) or severe protein-/energy malnutrition (E.43) were met; moderately malnourished if at least one criterion for 
moderate protein-/energy malnutrition (E.44.0) were met; or severely malnourished if at least one criterion for severe protein-
/energy malnutrition (E.43) were met, according to Table 9.   
c Categories: Not malnourished or malnourished (moderately and severely malnourished grouped).  
d Categories: Moderately malnourished or not moderately malnourished (well-nourished and severely malnourished grouped) 
e Categories: Severely malnourished or not severely malnourished (well-nourished and moderately malnourished grouped) 





Comparing GLIM malnutrition to ICD-10 malnutrition based on the categories well-
nourished or malnourished, both tools agreed on 72 patients being categorized as 
malnourished (true positives), and 162 patients as not malnourished (true negatives). 
However, GLIM categorized 42 patients as malnourished when ICD-10 categorized them as 
not (false positives), and ICD-10 categorized 50 patients as malnourished when GLIM 
categorized them as not (false negatives). There was fair agreement between GLIM and ICD-
10 for the diagnosis of malnutrition, kappa = 0.389 (p = .000), percent agreement 72%. When 
agreement between GLIM and ICD-10 was evaluated considering all three categories for the 
malnutrition diagnosis (i.e. no malnutrition, moderate malnutrition and severe malnutrition) 
there was fair agreement, kappa =0.314 (p = .000), percent agreement 63% (Data not 
presented). 
 
Comparing GLIM moderate malnutrition to ICD-10 moderate malnutrition, based on the 
categories moderately malnourished or not, both agreed on 17 patients being classified as 
moderately malnourished (true positives), and 211 patients as not moderately malnourished 
(true negatives). However, GLIM identified 24 patients as moderately malnourished when 
ICD-10 identified them as not (false positives), and ICD-10 identified 74 patients as 
moderately malnourished when GLIM identified them as not (false negatives). There was 
poor agreement between GLIM and ICD-10 for the diagnosis of moderate malnutrition, kappa 
= 0.102 (p = .039), percent agreement 70%.  
 
Comparing GLIM severe malnutrition to ICD-10 severe malnutrition, based on the categories 
severely malnourished or not, both agreed on 27 patients being classified as severely 
malnourished (true positives), and 249 patients as not severely malnourished (true negatives). 
However, GLIM identified 46 patients as severely malnourished when ICD-10 identified 
them as not (false positives), and ICD-10 identified 4 patients as severely malnourished when 
GLIM identified them as not (false negatives). There was moderate agreement between GLIM 
and ICD-10 for the diagnosis of severe malnutrition, kappa = 0.445 (p = .000), percent 
agreement 84%.  
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5. Discussion  
5.1. Main findings 
The overall aim of this thesis was to test the GLIM’s criterion validity in an inpatient 
population screened for nutritional risk, by using the ICD-10 diagnostic codes for moderate 
(E.44.0) and severe (E.43) malnutrition as reference; and to investigate the prevalence of 
malnutrition in the same population. For this section the main findings will be reviewed, 
followed by a discussion of the results and methods. Finally, a conclusion and implications 
for further research will be presented.   
 
GLIM’s overall ability to identify malnutrition was rated as fair (sensitivity 59.0%, specificity 
79.4%, k=0.389, fair agreement) when compared to ICD-10 (E.44.0 and E.43). GLIM’s 
performance was poor at identifying moderate malnutrition, as sensitivity fell to 18.7% with a 
specificity of 89.8% (k=0.102, poor agreement). However, GLIM was rated as good at 
identifying severely malnourished patients, with a sensitivity of 87.1% and specificity of 
84.4% (k= 0.445, moderate agreement). Of the potential combinations of phenotypic and 
etiologic criteria required for a GLIM malnutrition diagnosis, combination D: Low BMI (< 20 
or < 22 if > 70 years) and inflammation (CRP≥ 5 mg/dl) was the most frequent. For the GLIM 
diagnosis of moderate and severe malnutrition, the predominant phenotypic criteria were 
reduced muscle mass (MAMC < 10th percentile) and low BMI (< 18.5 or <20 if > 70 years), 
respectively. For the ICD-10 diagnoses of moderate (E.44.0) and severe (E.43) malnutrition, 
the predominant diagnostic criteria were reduced food intake (< 50% of ER for > 1 week) and 
low BMI (< 16 or < 18.5 if >70 years,) respectively.  
 
In this population of hospitalized patients at Haukeland University Hospital (HUH) 44% were 
identified as at nutritional risk by NRS-2002. Using the ICD-10 E.44.0 and E.43 criteria for 
malnutrition, 37% were identified as malnourished. Similar results were found applying the 
newly proposed GLIM criteria which identified 35% as malnourished. When considering 
malnutrition severity, ICD-10 identified a larger proportion as moderately malnourished 
(28%) than GLIM (13%), whereas GLIM identified a larger proportion as severely 
malnourished (22%) than ICD-10 (9.5%). Thus, estimates of overall malnutrition prevalence 
were approximately equal between both approaches, but it would seem as though GLIM is 




5.2. Discussion of results 
5.2.1. Population characteristics according to nutritional risk status 
With a few exceptions, the differences between the patients based on nutritional risk status are 
as expected. Being at nutritional risk is significantly associated with higher age, longer LOS, 
more comorbidity (higher number of diagnoses in total), as well as significantly lower total 
bodyweight, BMI and MAMC. These results are consistent with previous findings. Tangvik 
et. al. (20) investigated the nutritional status of inpatients at HUH, based on repeated 
prevalence surveys as part of a quality improvement project between 2008-2009. The study 
found that nutritional risk as defined by NRS-2002 was most prevalent in the very old (>80 
years), patients with low BMI (< 20.5 kg/m2) and patients with high comorbidity (> 7 
diagnoses). In another study conducted by Tangvik et al. (29), patients at nutritional risk had 
significantly longer LOS than those not at risk (mean 8.3 versus 5 days).  
 
5.2.2. According to malnutrition status 
The anthropometrical and nutritional features of the malnourished patients identified by ICD-
10 or GLIM are largely in line with expectations. For example, it is expected that 
malnourished patients have lower BMI than well-nourished and that BMI is further reduced 
with increasing degree of severity. This general trend was present for both diagnostic tools, 
except for no statistically significant difference in involuntary weight loss between GLIM 
well-nourished and malnourished. Interestingly, there is not found any difference in age, LOS, 
or comorbidities between ICD-10 well-nourished and malnourished, or between the 
moderately and severely malnourished. As for GLIM, the malnourished patients have longer 
LOS and more comorbidities than the well-nourished, and the severely malnourished have 
more comorbidities than the moderately malnourished. The number of well-nourished patients 
reporting food intake below 50% of ER the last week is higher in GLIM than in ICD-10. This 
is most likely explained by the ICD-10 E.44.0 criterion “Reduced food intake below 50% of 
ER the last week”, which is required to be matched with a phenotypic criterion to receive a 
GLIM diagnosis.  
 
The patient characteristics seen in Table 13 were presented in order to further investigate 
differences or similarities between patients identified as malnourished exclusively by GLIM or 
ICD-10. These findings suggest that exclusively GLIM malnourished are likely to be older, 
have longer LOS, and more comorbidity than exclusively ICD-10 malnourished. Furthermore, 
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the exclusively GLIM malnourished have lower BMI, more loss of muscle mass (assessed by 
MAMC), and more inflammation (assessed by CRP). On the other hand, exclusively ICD-10 
malnourished display lower total bodyweight and higher weight loss. Of note, these are 
observed differences and have not been tested statistically.  
 
5.2.3. Prevalence of nutritional risk and malnutrition  
The 44% prevalence of patients at nutritional risk is within the range (18.2-58.6%) of what 
has been reported in some studies of hospitalized patients using NRS-2002 (29, 68-71) 
(Kilder). In a study of 705 hospitalized patients in Brazil (71), 27.9% were classified as at 
nutritional risk by NRS-2002. The study also found that 38.9% of the at risk patients were 
malnourished according to SGA (classified as SGA B moderately or SGA C severely 
malnourished). In contrast, the results from this thesis show that GLIM and ICD-10 identified 
a higher proportion of the of the at-risk patients as malnourished, 54% and 73% respectively.  
 
The 35% prevalence of GLIM defined malnutrition is also within range (13.9-80%) of what 
has been reported in most studies applying the GLIM criteria in a hospital setting (26, 72-76). 
The highest prevalence (80%) is seen in advanced-stage cancer patients (72), however it is 
also prevalent in  in hospitalized elderly (74), which is in line with a growing body of 
evidence that malnutrition is frequently seen in higher age (77). As the average age is 
increasing in developed countries, there is subsequently more elderly being hospitalized (78). 
Henriksen et al. (79) highlighted an important challenge in the GLIM process. By applying 
four different validated screening tools (NRS 2002, MST, MUST, PG-SGA Short Form) to a 
population of patients with colorectal cancer, they found that depending on the screening tool, 
21-36% of patients were identified as at risk of malnutrition, and furthermore that 13-24% 
were diagnosed as malnourished by GLIM. This implies that the choice of screening used for 
the first step of the GLIM process, can influence the diagnostic outcome and therefore 
prevalence estimates. This potential limitation has been avoided for the current thesis. All 
patients were assessed using the GLIM criteria, skipping the first step of risk screening while 
being blinded to the NRS-2002 outcomes in order to avoid a biased assessment. However, the 
crosstabulations (Table 14) show that 37 patients were identified as not at nutritional risk by 
NRS-2002, while also identified as malnourished by GLIM. This suggests that some patients 
would not have been detected by GLIM, had the diagnostic assessment been based on the 
NRS-2002 outcome. Additionally, prevalence estimates are influenced by which methods are 
applied to assess the muscle mass and inflammation criteria. This was demonstrated in a 
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retrospective analysis of community-dwelling elderly, where applying seven different 
approaches to measure reduced muscle mass resulted in GLIM malnutrition prevalence 
between 13.9% to 20.9% (80).   
 
5.2.4. Validity and agreement.  
The current study has demonstrated that GLIM has fair agreement (k=0.389) with ICD-10 
(E.44.0 and E.43), with a sensitivity of 59%, specificity of 79.4%, and PPV of 63.2% and of 
NPV 76.4%. These results suggest that GLIM has fair criterion validity for the diagnosis of 
malnutrition. However, when considering GLIM’s accuracy in identifying severity grades of 
malnutrition the results are inconsistent. The discrepancy between GLIM and ICD-10 could 
be explained by a difference in indicators included, and their cut-offs. The GLIM criteria 
consist of five indicators of malnutrition, while ICD-10 consists of four indicators of 
moderate malnutrition and three indicators of severe malnutrition. Exclusive to GLIM is the 
phenotypic criteria of muscle mass, and the etiologic criteria of inflammation. As for ICD-10, 
low food intake as an indicator is only used for moderate malnutrition. Furthermore, the 
common indicators used by the two tools use different cut-offs to distinguish between severity 
grades. For example GLIM requires a BMI below 18 kg/m2 for the diagnosis of severe 
malnutrition, while ICD-10 requires a BMI below 16 kg/m2 for the same diagnosis. Thus, 
GLIM will be more sensitive to changes in BMI and potentially identify more people as 
severely malnourished as a result, while a much larger reduction in BMI would be required 
for the same diagnosis by ICD-10.  
 
According to the GLIM committee recommendations for validation studies (62), criterion 
validity should be assessed using SGA as a semi-gold standard reference. Although the 
literature is scarce, there are some published studies assessing the validity of the GLIM 
criteria in hospitalized patients using SGA as reference.  
 
In a prospective cohort study (75) on adult/elderly patients from all units (excluding 
emergency and intensive care units) found that GLIM had satisfactory criterion validity, with 
a sensitivity of 86.6%, specificity of 81.6%, PPV of 70.8%, NPV of 92.3%, and k= 0.648 
(p<0.001) when using SGA as reference. These results are an improvement to the ones found 
in the present thesis. However, when comparing GLIM severity grading with SGA, similar 
results were found with crude agreement between the two tools in 64.5% and 76.6% of 
moderately (GLIM Stage 1 and SGA-B) and severely (GLIM Stage 2 and SGA-C) 
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malnourished patients, respectively. Here the GLIM criteria were applied in full. The presence 
of inflammation was indicated by CRP > 5 mg/dl, and reduced muscle mass was assessed by 
a full physical assessment as well as calf-circumference (CC). However, reduced muscle mass 
was not used in the severity grading due to a lack of guidelines on relevant cut-off values for 
CC. Furthermore, the study found that the most predominant phenotypic criteria was reduced 
muscle mass which was observed in 86.8% of malnourished patients. Due to differences in 
methods, the descriptives on phenotypic criteria from the present thesis cannot be directly 
compared. However, loss of muscle mass was the most severe phenotypic criterion used for 
classification in 36% of moderately and 30% of severely malnourished patients in the present 
thesis. Taken all together, this implies that low muscle mass is frequent in malnourished 
patients and is an important component of a nutritional assessment.   
 
In an Australian cross-sectional observational study (81) of adult ambulatory cancer care 
patients, it was concluded that GLIM had fair criterion validity with a sensitivity of 76%, 
specificity of 73%, PPV of 34%, NPV of 94% and kappa= 0.32, when using PG-SGA as 
reference. This study was limited in that only weight history the last six months and BMI 
could be assessed of the phenotypic criteria, and the etiologic criterion of inflammation was 
assumed present on the basis of cancer as an inflammatory condition.  
 
A similar approach to the present thesis was applied in a retrospective analysis of nutritional 
parameters from a prospective cohort study assessing malnutrition at admission to 18 
Canadian hospitals (73). The study did not have data on the phenotypic criterion for loss of 
muscle mass, so four combinations of the phenotypic criteria “weight loss” and “low BMI”, 
coupled with the etiologic criteria “low food intake” and “inflammation”, was compared to 
SGA. A CRP > 8 mg/dl was used to determine the presence of inflammation. The study found 
that GLIM had fair criterion validity regardless of severity status, with a sensitivity of 61.30% 
specificity of 89.77%, PPV of 83.14% and NPV of 73.80%. Similarly, (Kappa was not 
reported). Although the results differ somewhat from the present thesis, the authors found that 
when comparing only GLIM severely malnourished with SGA C (severely malnourished) 
sensitivity improved to 76.09%, specificity to 87.7%, and NPV to 96.5%, while PPV was 
reduced to 45.2%. These findings support the ones from the present thesis, that GLIM tends to 
have better diagnostic accuracy towards the severely malnourished patients. Furthermore, 
when using combinations of phenotypic and etiologic criteria on their own, e.g. only low BMI 
and reduced food intake versus SGA, all phenotypic/etiologic combinations were rated as 
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poor, as no combination had a sensitivity above 50%. The authors therefore concluded that all 
GLIM criteria combinations should be assessed in order to correctly identify malnutrition. 
This strengthens the current thesis, as all GLIM criteria were applied during assessment.    
 
5.3. Discussion of methods 
5.3.1. Study design 
The patient population used for analysis in the current thesis was originally recruited to the 
MALNUTRA-study. The MALNUTRA-study had a matched cohort design, utilizing a non-
probability sampling technique. This can lead to selection bias, as it is no longer a randomized 
participant recruitment process (54). Sampling at the wards was done by convenience, 
meaning that potential and available participants at the wards were informed in writing or 
orally regarding the study procedure, before consenting or not. Patients who declined 
participation were older (median 77 vs.  71 years) than the patients who consented, and one of 
the most frequent reasons for non-participation was “feeling unwell/study too demanding”. 
Therefore, it is not unlikely that the point prevalence estimate of malnutrition could be 
suppressed by selection bias, as it is well documented that malnutrition is more common in 
the elderly and in patients with multiple comorbidities (20). Selection bias is also displayed by 
the exclusion of patient populations known to have a higher proportion of nutritional risk or 
malnutrition (e.g. cancer and acute care patients (20) and by the fact that 76% of the patient 
population was recruited from two departments alone. Taking this into account, extrapolating 
the results to a general inpatient population may be inappropriate.   
 
The present thesis is a retrospective cross-sectional analysis of inpatient data collected at the 
time of inclusion to the MALNUTRA-study. Applied to the context of the current thesis, a 
cross-sectional design can be utilized to determine the presence or absence of nutritional risk 
or malnutrition for all patients in a sample population at a single point in time, often compared 
to a “snapshot”, e.g. at inclusion. The cross-sectional design is also subject to certain 
limitations. The “snapshot” characteristic implies that associations can be investigated, but 
causality cannot be established. For example, patients identified as malnourished by both 
GLIM and ICD-10 reported significantly lower food intake compared to the well-nourished 
patients. Thus, reported low food intake at inclusion is associated with malnutrition, but it 
cannot be deduced as the causal factor for the patients’ malnourished state. Nonetheless, the 
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cross-sectional is suitable for descriptive analysis and determining point prevalence of 
nutritional risk and malnutrition.  
 
5.3.2. Statistics 
5.3.2.1. Validity statistics 
In line with the GLIM committee recommendations for validation studies (62), sensitivity, 
specificity, positive predictive value and negative predictive value has been reported in the 
assessment of GLIM’s criterion validity. The literature lacks guidelines for optimal cutoff 
points for sensitivity and specificity (82). This is because diagnostic tests optimal sensitivity 
and specificity is dependent on the consequences of identifying false negatives and false 
positives (54). Ideally, a tool has both high sensitivity (i.e. a low number of truly well-
nourished wrongly classified as malnourished) and high specificity (i.e. a low number of truly 
malnourished classified as well-nourished). In clinical practice a balance has to be struck 
between the two (54). For this thesis, cut-off values for sensitivity and specificity described 
by van Bokhorst-de van der Schueren et. al (65), was applied in order to rate the GLIM 
criteria’s performance. Alternatively, the GLIM committee recommendations require Se, Sp 
and kappa > 80% for the GLIM criteria’s diagnostic performance to be acceptable (62). Had 
this cut-off been applied to the current thesis, then only the sensitivity and specificity found 
when comparing GLIM and ICD-10 severely malnourished would have been satisfactory. It 
could be argued that these values are chosen somewhat arbitrarily, and therefore the 
sensitivity and specificity percentages are presented in full so that individual interpretation is 
possible. As for NPV’s and PPV’s of a test, it is important to consider the impact of 
prevalence (83). When prevalence decreases, so does PPV, while NPV increases. Reversely, 
when prevalence increases, so does PPV, while NPV decreases.  
 
5.3.2.2. Agreement statistics 
A screening or assessment tools reliability can be defined as the measure of agreement 
between the results of the tool when more than one user applies it to the same subject (84). 
This is commonly referred to as inter-rater reliability (IRR). For the present thesis, there was 
only one rater, assessing the agreement between two methods of assessment i.e. ICD-10 and 
GLIM. Therefore, the term “agreement” has been used instead of IRR. The simplest measure 
or agreement is by calculating the “Percent Agreement” i.e. the number of patients in which 
both tools agreed divided by the total number of agreements and disagreements. However, 
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this method does not account for chance agreement. To account for this, Cohen’s Kappa has 
been calculated. There are several proposed ways to interpret kappa values in the literature, 
varying in both numerical cut-off values as well as in rating. For example, an alternative way 
to interpret a kappa value between 0.4 and 0.6 is as “weak” (85) and not “good” as in the 
current thesis. Thus, ratings of agreement can vary between studies despite identical kappa-
values.  
 
5.3.3. Using ICD-10 as reference 
For the assessment of criterion validity of any tool, there should be a comparison of the new 
tool’s assessment of nutritional status with an assessment obtained by a gold standard 
procedure (60). By this definition, the GLIM criteria would have to be compared to a gold 
standard reference for diagnosing malnutrition. As previously mentioned, a gold standard for 
defining malnutrition is absent. However, a full nutritional assessment by e.g. a dietitian, has 
been proposed as a “semi-gold standard (57). In addition, more comprehensive assessment 
tools such as the SGA, has been validated against full nutrition assessment by a clinician and 
is therefore considered more appropriate, albeit less conclusive, than a full clinical assessment 
(40). For the present thesis, ICD-10 has been used as reference for all analysis. This is in part 
because of the available parameters from the MALNUTRA-database. The comprehensive and 
subjective assessments that are part of the SGA also made this tool unapplicable in a 
retrospective analysis. This is limiting the overall results of the assessment of GLIM’s 
criterion validity. A tool can only be as good as the reference it is measured by, and ICD-10 is 
likely to be outdated as the understanding of malnutrition has grown and the definition 
evolved since it was first published. Nonetheless, the ICD-10 is what clinicians are using 
every day and therefore it is of value to investigate how well the two diagnostic approaches 
agree. It is worth noting that the GLIM committee is working with the WHO to incorporate 
the GLIM criteria into the new ICD-11 (4).  
 
5.3.4. The nutritional assessment procedure 
The current thesis is a retrospective analysis of nutritional and anthropometric data collected 
in the MALNUTRA-study. As the available data was not originally intended for diagnostic 
assessment, some modification/simplification of the ICD-10 and GLIM criteria had to be 
made. With relevance for the ICD-10 criteria, weight loss beyond 3 months or during specific 
time intervals (e.g. 1 or 2 months) within 3 months could not be assessed. The presence or 
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absence of any acute/chronic inflammatory condition concurrent with a reduction in reduced 
food intake the last week has not been considered either. This is due to the design of the 
MALNUTRA-questionnaire, where patients reported weight history for the last 3 months 
only, and questions regarding food intake the last week did not include assessment of 
simultaneous disease activity. Since CRP was measured at admission to the hospital, this 
could not be applied as a measure of disease-related inflammation for the week prior to 
hospitalization. Similarly, the GLIM assessment did not consider weight loss beyond 3 
months, reductions in food intake beyond 1 week, or the presence or absence of chronic GI 
conditions that could adversely affect absorption of nutrients. Obtaining information 
regarding patients’ medical history and disease activity is a common part of any clinical 
nutritional assessment process. However, this is highly subjective, and it is difficult to draw 
any conclusions as to the impact of a condition based on a diagnosis alone. For example, it 
would be impossible to know retrospectively if a patient with Crohn’s disease was in 
remission or in an active phase at the time of inclusion, which would impact nutrient 
absorption. Thus, information regarding patients’ diagnoses was not included in the 
nutritional assessment. Taken together, the validation of GLIM is limited by the fact that the 
criteria were not applied fully as described in the consensus report.  
 
When assessing the patients using the GLIM and ICD-10 criteria, the criteria of most severe 
degree would be used to support a diagnosis. As in clinical practice, malnutrition does not 
necessarily present only as low BMI, or only as a consequence of low food intake. Therefore 
a prioritized sequence was made in advance, guiding the selection of diagnostic criteria in 
cases with multiple equally severe criteria. The sequence was made to reflect clinical practice 
where it could be argued that the easiest, most attainable criteria are more likely to be used. 
This introduces bias to the results, as they only describe the select criteria for diagnosis, and 
do not reflect the total prevalence of any given criterion. Thus, it is expected that the 
prevalence of malnutrition defined by e.g. reduced muscle mass is underreported as it is 
placed last in the aforementioned sequence. However, this does not affect the overall 
prevalence estimates of malnutrition, nor the result of the severity classification.   
 
The following section will discuss the applied methods for measuring the nutritional and 




5.3.5. Reduced muscle mass  
According to GLIM, loss of muscle mass can be measured by any validated body composition 
method (4). The anthropometric measure of mid arm muscle circumference (MAMC) was 
used for assessment of reduced muscle mass. MAMC is calculated from skinfold thickness 
(SFT) and mid upper arm circumference (MUAC). MAMC is a simple, non-invasive and 
inexpensive procedure that used to assess malnutrition by using muscle size as an index of 
protein reserves (54). Low MAMC has been shown to be an independent predictor of 
mortality in hemodialysis patients (86), and in a study on community dwelling elderly (>80 
years) higher MAMC was associated with lower mortality risk and better functional status 
(87). As any anthropometric measurement, MAMC suffers from some limitations. Random 
measurement errors in measuring SFT and MUAC cannot be excluded, although standardized 
procedures were carried out by trained dietitians and masters’ students. Perhaps most 
importantly, is the choice of reference values to interpret the results. There are no 
international population standards available for MAMC (46). Published cut-off values by 
Symreng et al. (63) were applied. Here values below the 10th percentile and the 5th percentile 
are interpreted as moderate and severe malnutrition, respectively. The values are based on a 
Swedish reference population of 1860 healthy men and women between 20 and 101 years, 
later validated in a gastroenterological population. Although not validated in the current 
population, the reference data should be more appropriate in terms of ethnicity than values 
from e.g. American populations. Another strength is its wide age band (20-89 years).  
 
5.3.6. Inflammation 
CRP was selected as a biochemical indicator for the presence of inflammation. The chosen 
cut-off was in line with ESPEN guidelines (10) which suggest CRP > 5 mg/L as the lowest 
limit of inflammation that is relevant for DRM with inflammation. However, GLIM (4) 
recommends to primarily assess the clinical diagnosis and associated inflammation and to use 
CRP as a supportive measure. This subjective approach requires some degree of clinical 
experience and is difficult to accomplish retrospectively. Thus, an objective assessment of 
CRP was considered a better approach for this thesis. Other studies have defined cut-off 
values of CRP > 2 mg/dl (88) or CRP > 8 mg/dl (73), which underscores that there is a lack of 
guidelines on how to best objectively assess not only the etiologic criterion of inflammation, 




5.3.7. Weight loss and food intake history  
Data on weight loss and food intake used in the nutritional assessment is self-reported data 
from the MALNUTRA-questionnaire (Appendix 1). These data are dependent on the patient’s 
memory and could suffer from measurement error and their value be discussed. Furthermore, 
the questionnaire was not validated prior to use.  
 
5.4. Conclusion 
The GLIM criteria displayed fair criterion validity (Se 59.0%, Sp 79.4%) and agreement 
(k=0.389, agreement 72%) when compared to the ICD-10 diagnostic codes E.44.0 and E.43. 
When compared based on moderate malnutrition status, the GLIM criteria’s criterion validity 
fell to poor rating (Se 18.7%, Sp 89.8%) and agreement was poor (k=0.102, agreement 70%) 
when compared to ICD-10 E.44.0. However, when compared based on severe malnutrition 
status the GLIM criteria displayed good criterion validity (Se 87.1%, Sp 84.4%) and moderate 
agreement (k=0.445, agreement 85%) when compared to ICD-10 E.43. In this population of 
inpatients at Haukeland University Hospital, the prevalence of nutritional risk (E.46) as 
identified by NRS-2002 was 44%. The prevalence of malnourished as identified by ICD-10 
was 37%, of which 28% were moderately malnourished (E.44.0) and 9.5% were severely 
malnourished (E.43). The newly proposed GLIM criteria identified 35% as malnourished, of 
which 13% were moderately malnourished and 22% were severely malnourished. Taken 
together, while GLIM seems to identify a similar total number of malnourished patients as 
ICD-10, the approach can also result in a higher proportion of severely malnourished patients. 
Lastly, the predominant criteria for diagnosing moderate and severe malnutrition using ICD-
10, was “reduced food intake” (45% of diagnoses) and low BMI (55% of diagnoses), 
respectively. As for GLIM, the predominant phenotypic criteria used for severity grading into 
moderate and severe malnutrition was “reduced muscle mass” assessed by MAMC (36% of 









5.5. Implications for future research   
Guidelines from the GLIM committee on how to best assess muscle mass and disease-related 
inflammation in a clinical setting are warranted. Preferably, this should include consulting 
clinicians to identify methods that are readily available and easily applied to clinical practice. 
Furthermore, these guidelines should provide cut-off points for severity grading based on the 
extent of muscle mass loss. Following such guidelines, there should be more prospective 
studies designed to validate the full GLIM criteria, as it seems that retrospective studies are 
limited by the combability of available parameters. It is evident that assessment of body 
composition, especially muscle mass, is of importance when evaluating nutritional status. An 
important question is whether this should be better implemented in routine nutritional 
assessment along with more traditional indicators such as BMI, weight loss or food intake. 
Lastly, there should be more prospective studies investigating if the patients identified as 




Appendix I: MALNUTRA general questionnaire (page 1) 
 
 
Pasient ID:                                                                                               Dato: 
Kjønn:  
 
Vekt: ________kg  
Vekten din for 5 år siden? ____________kg     vet ikke ⃝ 
Vekt din da du var 18 år gammel?   _______kg   vet ikke ⃝ 
Er du fornøyd med vekten din nå?  Ja ⃝      nei, for lett ⃝    nei, for  tung ⃝  
Har du prøvd å slanke deg i løpet av de siste 10 årene?   
Nei ⃝  ja, en gang ⃝   ja, mange ganger ⃝ 
 
Har du hatt ufrivillig vekttap siste 3 måneder? 
Ja ⃝           nei ⃝  nei, jeg har gått opp i vekt ⃝ jeg vet ikke ⃝ 
Hvis ja, hvor mange kilo har du gått ned?   Ca. _____________kg  
Hvor mye har du spist den siste uken  
Normalt ⃝     litt mindre enn normalt ⃝ 
mindre enn halvparten av normalt⃝  mindre enn en fjerdedel av normalt⃝ 
Jeg spiste mindre fordi 
Jeg hadde ikke matlyst ⃝    jeg er kvalm ⃝ 
Jeg har problemer med å tygge/svelge ⃝ annet _____________________ 
 
Syns du at det er greit med vektnedgang?  Ja ⃝  nei ⃝ 
Hvor fornøyd er du med dine spisevaner?  
Svært fornøyd  1   2   3   4   5   6   7   8   9   10  svært misfornøyd  
 
Har du følt at du veier for mye?  
Ikke i det hele tatt  1   2   3   4   5   6   7   8   9   10  hver dag  
 
Høyde: _________cm  
Din høyde da du var 18 år gammel?    _______cm vet ikke ⃝ 
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1. INTRODUKSJON 





Det er den som gjennomfører målingen som har ansvar for at denne prosedyren 
benyttes ved måling av høyde. Det er leder for studien som har ansvar for at ansatte 




Målinger gjennomføres med Seca modell 217 (Figur 1). 
 
 





                                                                                                                        Figur 1. Stadiometer 
Om instrumentet: 
 
Det mobile stadiometeret består av 7 deler som settes sammen før måling. Øverst festes et toppstykke 
som holder målestangen i avstand fra veggen, og forhindrer bevegelse som kan gjøre målingen 
unøyaktig.  
 
4. BESKRIVELSE OG PROSEDYRE 
Kontraindikasjoner: 
Dersom deltageren ikke er i stand til å stå oppreist, kan ikke måling gjennomføres.  
 
Deltagerforberedelser: Informer om prosedyre og gjennomføring. 
 
Gjennomføring av måling: 
1. Høyde skal måles uten sko med lette klær til nærmeste 0,1 cm.  
2. Deltageren må ha føttene samlet, armene langs siden, strake bein og avslappede skuldre. Hodet 
må være i Frankfurt horisontale plan (ser rett framover; figur 2). Heler, rumpe, skulderblader og 
baksiden av hodet må være inntil den vertikale målestolpen.  
3. Måling gjennomføres en gang, ved maksimal inspirasjon. 
4. Dersom deltageren ikke er i stand til å stå oppreist kan man spørre etter hvilken høyde som står i 
passet.  















Figur 2. Måling av høyde med korrekt hodeplassering 
 
Avvik og nøyaktighet: 
Måling av høyde gjennomføres til samme tid hver dag, helst ettermiddag.  
I tilfeller der overvekt forhindrer deltageren å ha heler, rumpe og skuldre inntil stadiometeret, bes 
deltageren om å stå strak (1, s. 247-248).  
 













Vedlegg 1: Bruksanvisning, Seca 217 
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1. INTRODUKSJON 





Det er den som gjennomfører målingen som har ansvar for at denne prosedyren benyttes ved måling 
av vekt. Det er leder for studien som har ansvar for at ansatte som jobber med studien har tilstrekkelig 












Vekten bør plasseres på en hard overflate. Den skrus på ved å tråkke lett på overflaten. Før måling må 






Måling gjennomføres ikke dersom deltageren ikke kan stå selv, evt. at det ikke er tilgjengelig stolvekt 
eller sengevekt. Maks vekt er 200kg. 
 
Deltagerforberedelser:  














Gjennomføring av veiing: 
1. Dersom deltageren ikke kan stå selv, men det er tilgjengelig en stolvekt på avdelingen, kan denne 
benyttes. Sjekk da at vektene viser samme vekt, ved at prosjektmedarbeider selv måler seg på 
begge vekter.  
2. Måling gjennomføres en gang.  
 
Avvik og nøyaktighet: 
Måling av vekt bør helst gjennomføres om morgenen etter at blæren er tømt, og før første måltid.  
Dersom deltageren har ødemer må dette noteres (1, s. 252-253).  
 




Desinfiseres med kommerstelt tilgjengelig middel.  
 
6. KALIBRERING: 
Ved behov for kalibrering kontaktes: 
 
Teck-Ho Service AS 
Mailadresse: post@teckhoservice.no 









Vedlegg 1: Bruksanvisning, Seca 877. 
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1. INTRODUKSJON 
Denne prosedyren skal benyttes ved måling av hudfoldtykkelse, med mål om å sikre korrekte og 
ensartede målinger. 
 
Kalipperen brukers til å måle tykkelse av det subkutane fettvevet på ulike områder på kroppen som for 
eksempel: biceps, triceps, hofte, skulder og mage. Som kan gi et indirekte estimat av totalt kroppsfett. 
 
2. ANSVAR 
Det er den som gjennomfører målingen som har ansvar for at denne prosedyren benyttes ved måling 
av hudfoldtykkelse. Det er leder for studien som har ansvar for at ansatte som jobber med studien har 




Målinger gjennomføres med Lange skinfold kaliper 
 
Om instrumentet: 
Tallskivene viser i milimeter fra 0- 67. For å åpne kalipperen trykker en inn den grønne hendelen og 
når en skal lukke denne skal en slippe forsiktig. 
 
4. PROSEDYRE 
Adaptert og oversatt fra brukerveiledning (vedlegg 1).   
 
Kontraindikasjoner: Måling skal ikke gjennomføres dersom deltageren har ødemer i armene.  
 
Deltagerforberedelser: Forklar deltager hva målingen går ut på. Be så deltageren om å reise seg 
opp å stå oppreist gjennom prosedyren. 
 
Gjennomføring av måling; triceps og biceps: 
1. Deltagerens arm skal hvile langs kroppen med håndflaten mot kroppen. 
2. Ta tak i hud og underhudsfett med pekefinger og tommel 1 cm over merket fra MUAC-måling. 
3. Plasser kaliperen 1 cm under der men holder på baksiden av armen. Huden holdes fast mens 
målingen avleses. Vent 2-3 sek fra kaliperen er plassert til avlesning. 
4. Vent min. 15 sek før neste måling gjennomføres. 
5. Biceps hudfoldtykkelse måles på tilsvarende måte, men på forsiden av armen. 
6. Begge måles tre ganger, en bruker gjennomsnittet som resultat 
 
Avvik og nøyaktighet: 



















Kan tørkes av med en fuktig klut. Klypene kan desinfiseres.   
 
6. KALIBRERING 
Gjennomføres ved hjelp av måleblokk. Plasser kalipperen på de ulike trinnene av måleblokken og 
sammenlign målingene med mål på blokken.  
 




Vedlegg 1: Lange skinfold caliper, Beta Technology 
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1. INTRODUKSJON 





Det er den som gjennomfører målingen som har ansvar for at denne prosedyren benyttes ved måling 
av MUAC. Det er leder for studien som har ansvar for at ansatte som jobber med studien har 













Om deltageren ikke kan sitte eller stå. 
 
Deltagerforbederedelser:  
Informer deltageren om gjennomføringen av målingen og be deltageren ta av seg genser eller jakke. 
 
Gjennomføring av måling: 
1. Marker midten av overarmen: Deltagerens arm skal være i 90 graders vinkel med håndflaten opp. 
Punktet finnes midt mellom acromion på scapula og ytterst på albuen, oclecranon på ulna. 
2. Deltageren skal stå oppreist, beina litt fra hverandre og armene avslappet ned langs siden med 
håndflaten innover. Om en må ta målingen liggende skal en plassere et brettet håndkle eller pute 
under albuen slik at armen kommer opp fra underlaget.  
3. En skriver ned målingen til nærmeste 0,1 cm. 
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